<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="other"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Bull World Health Organ</journal-id><journal-id journal-id-type="iso-abbrev">Bull. World Health Organ</journal-id><journal-id journal-id-type="publisher-id">BLT</journal-id><journal-title-group><journal-title>Bulletin of the World Health Organization</journal-title></journal-title-group><issn pub-type="ppub">0042-9686</issn><issn pub-type="epub">1564-0604</issn><publisher><publisher-name>World Health Organization</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">30728619</article-id><article-id pub-id-type="pmc">6357573</article-id><article-id pub-id-type="publisher-id">BLT.18.220483</article-id><article-id pub-id-type="doi">10.2471/BLT.18.220483</article-id><article-categories><subj-group subj-group-type="heading"><subject>Policy &#x00026; Practice</subject></subj-group></article-categories><title-group><article-title>Implementation of national action plans on noncommunicable diseases, Bhutan, Cambodia, Indonesia, Philippines, Sri Lanka, Thailand and Viet Nam</article-title><trans-title-group xml:lang="fr"><trans-title xml:lang="fr">Mise en &#x00153;uvre de plans d'action nationaux sur les maladies non transmissibles au Bhoutan, au Cambodge, en Indon&#x000e9;sie, aux Philippines, au Sri Lanka, en Tha&#x000ef;lande et au Viet Nam</trans-title></trans-title-group><trans-title-group xml:lang="es"><trans-title xml:lang="es">Aplicaci&#x000f3;n de planes de acci&#x000f3;n nacionales sobre las enfermedades no contagiosas, Bhut&#x000e1;n, Camboya, Filipinas, Indonesia, Sri Lanka, Tailandia y Vietnam</trans-title></trans-title-group><trans-title-group xml:lang="ar"><trans-title xml:lang="ar">&#x0062a;&#x00646;&#x00641;&#x0064a;&#x00630; &#x0062e;&#x00637;&#x00637; &#x00639;&#x00645;&#x00644; &#x00648;&#x00637;&#x00646;&#x0064a;&#x00629; &#x00628;&#x00634;&#x00623;&#x00646; &#x00627;&#x00644;&#x00623;&#x00645;&#x00631;&#x00627;&#x00636; &#x0063a;&#x0064a;&#x00631; &#x00627;&#x00644;&#x00645;&#x00639;&#x0062f;&#x0064a;&#x00629;&#x0060c; &#x00625;&#x00646;&#x0062f;&#x00648;&#x00646;&#x0064a;&#x00633;&#x0064a;&#x00627; &#x00648;&#x00627;&#x00644;&#x00641;&#x00644;&#x00628;&#x0064a;&#x00646; &#x00648;&#x00628;&#x00648;&#x0062a;&#x00627;&#x00646; &#x00648;&#x0062a;&#x00627;&#x0064a;&#x00644;&#x00646;&#x0062f; &#x00648;&#x00633;&#x00631;&#x0064a; &#x00644;&#x00627;&#x00646;&#x00643;&#x00627; &#x00648;&#x00641;&#x0064a;&#x0064a;&#x0062a; &#x00646;&#x00627;&#x00645; &#x00648;&#x00643;&#x00645;&#x00628;&#x00648;&#x0062f;&#x0064a;&#x00627; </trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title xml:lang="zh">&#x04e0d;&#x04e39;&#x03001;&#x083f2;&#x05f8b;&#x05bbe;&#x03001;&#x067ec;&#x057d4;&#x05be8;&#x03001;&#x065af;&#x091cc;&#x05170;&#x05361;&#x03001;&#x06cf0;&#x056fd;&#x03001;&#x05370;&#x05ea6;&#x05c3c;&#x0897f;&#x04e9a;&#x03001;&#x08d8a;&#x05357;&#x07684;&#x0975e;&#x04f20;&#x067d3;&#x06027;&#x075be;&#x075c5;&#x056fd;&#x05bb6;&#x0884c;&#x052a8;&#x08ba1;&#x05212;&#x07684;&#x05b9e;&#x065bd;</trans-title></trans-title-group><trans-title-group xml:lang="ru"><trans-title xml:lang="ru">&#x0041e;&#x00441;&#x00443;&#x00449;&#x00435;&#x00441;&#x00442;&#x00432;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x00435; &#x0043d;&#x00430;&#x00446;&#x00438;&#x0043e;&#x0043d;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00445; &#x0043f;&#x0043b;&#x00430;&#x0043d;&#x0043e;&#x00432; &#x00434;&#x00435;&#x00439;&#x00441;&#x00442;&#x00432;&#x00438;&#x00439; &#x00432; &#x0043e;&#x00442;&#x0043d;&#x0043e;&#x00448;&#x00435;&#x0043d;&#x00438;&#x00438; &#x0043d;&#x00435;&#x00438;&#x0043d;&#x00444;&#x00435;&#x0043a;&#x00446;&#x00438;&#x0043e;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x00437;&#x00430;&#x00431;&#x0043e;&#x0043b;&#x00435;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00439; &#x00432; &#x00411;&#x00443;&#x00442;&#x00430;&#x0043d;&#x00435;, &#x00412;&#x0044c;&#x00435;&#x00442;&#x0043d;&#x00430;&#x0043c;&#x00435;, &#x00418;&#x0043d;&#x00434;&#x0043e;&#x0043d;&#x00435;&#x00437;&#x00438;&#x00438;, &#x0041a;&#x00430;&#x0043c;&#x00431;&#x0043e;&#x00434;&#x00436;&#x00435;, &#x00422;&#x00430;&#x00438;&#x0043b;&#x00430;&#x0043d;&#x00434;&#x00435;, &#x0043d;&#x00430; &#x00424;&#x00438;&#x0043b;&#x00438;&#x0043f;&#x0043f;&#x00438;&#x0043d;&#x00430;&#x00445; &#x00438; &#x00432; &#x00428;&#x00440;&#x00438;-&#x0041b;&#x00430;&#x0043d;&#x0043a;&#x00435;</trans-title></trans-title-group><alt-title alt-title-type="author-running-head">Titiporn Tuangratananon et al.</alt-title><alt-title alt-title-type="title-running-head">National action plans on noncommunicable diseases in Asia</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tuangratananon</surname><given-names>Titiporn</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wangmo</surname><given-names>Sangay</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Widanapathirana</surname><given-names>Nimali</given-names></name><xref ref-type="aff" rid="aff2"><sup>b</sup></xref></contrib><contrib contrib-type="author"><name><surname>Pongutta</surname><given-names>Suladda</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Viriyathorn</surname><given-names>Shaheda</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Patcharanarumol</surname><given-names>Walaiporn</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><contrib contrib-type="author"><name><surname>Thin</surname><given-names>Kouland</given-names></name><xref ref-type="aff" rid="aff3"><sup>c</sup></xref></contrib><contrib contrib-type="author"><name><surname>Nagpal</surname><given-names>Somil</given-names></name><xref ref-type="aff" rid="aff4"><sup>d</sup></xref></contrib><contrib contrib-type="author"><name><surname>Nuevo</surname><given-names>Christian Edward L</given-names></name><xref ref-type="aff" rid="aff5"><sup>e</sup></xref></contrib><contrib contrib-type="author"><name><surname>Padmawati</surname><given-names>Retna Siwi</given-names></name><xref ref-type="aff" rid="aff6"><sup>f</sup></xref></contrib><contrib contrib-type="author"><name><surname>Puyat-Murga</surname><given-names>Maria Elizabeth</given-names></name><xref ref-type="aff" rid="aff7"><sup>g</sup></xref></contrib><contrib contrib-type="author"><name><surname>Trisnantoro</surname><given-names>Laksono</given-names></name><xref ref-type="aff" rid="aff8"><sup>h</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wangmo</surname><given-names>Kinzang</given-names></name><xref ref-type="aff" rid="aff9"><sup>i</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wellappuli</surname><given-names>Nalinda</given-names></name><xref ref-type="aff" rid="aff10"><sup>j</sup></xref></contrib><contrib contrib-type="author"><name><surname>Thi</surname><given-names>Phuong Hoang</given-names></name><xref ref-type="aff" rid="aff11"><sup>k</sup></xref></contrib><contrib contrib-type="author"><name><surname>Anh</surname><given-names>Tuan Khuong</given-names></name><xref ref-type="aff" rid="aff11"><sup>k</sup></xref></contrib><contrib contrib-type="author"><name><surname>Zangmo</surname><given-names>Thinley</given-names></name><xref ref-type="aff" rid="aff12"><sup>l</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Tangcharoensathien</surname><given-names>Viroj</given-names></name><xref ref-type="aff" rid="aff1"><sup>a</sup></xref></contrib><aff id="aff1"><label>a</label>International Health Policy Program, Ministry of Public Health, Tivanond Road, Muang District, Nonthaburi <addr-line>11000, <country>Thailand</country></addr-line>.</aff><aff id="aff2"><label>b</label>Nutrition and Indigenous Medicine, <institution>Ministry of Health</institution>, <addr-line>Colombo</addr-line>, <country>Sri Lanka</country>.</aff><aff id="aff3"><label>c</label><institution>Swiss Agency for Development and Cooperation</institution>, <addr-line>Phnom Penh</addr-line>, <country>Cambodia</country>.</aff><aff id="aff4"><label>d</label>Global Practice on Health, Nutrition and Population, <institution>World Bank</institution>, <addr-line>Phnom Penh</addr-line>, <country>Cambodia</country>.</aff><aff id="aff5"><label>e</label><institution>Department of Health</institution>, <addr-line>Manila</addr-line>, <country>Philippines</country>.</aff><aff id="aff6"><label>f</label>Faculty of Medicine, Public Health and Nursing, <institution>Universitas Gadjah Mada</institution>, <addr-line>Yogyakarta</addr-line>, <country>Indonesia</country>.</aff><aff id="aff7"><label>g</label>Health Sciences Programme, <institution>Ateneo de Manila University</institution>, <addr-line>Manila</addr-line>, <country>Philippines</country>.</aff><aff id="aff8"><label>h</label>School of Medicine, <institution>Gadjah Mada University</institution>, <addr-line>Yogyakarta</addr-line>, <country>Indonesia</country>.</aff><aff id="aff9"><label>i</label>Policy and Planning Division, <institution>Ministry of Health</institution>, <addr-line>Thimphu</addr-line>, <country>Bhutan</country>.</aff><aff id="aff10"><label>j</label>Management Development and Planning Unit, <institution>Ministry of Health</institution>, <addr-line>Colombo</addr-line>, <country>Sri Lanka</country>.</aff><aff id="aff11"><label>k</label>Health Strategy and Policy Institute, <institution>Ministry of Health</institution>, <addr-line>Hanoi</addr-line>, <country>Vietnam</country>.</aff><aff id="aff12"><label>l</label>Health Promotion Division, Ministry of Health, Thimpu, <country>Bhutan</country>.</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to Viroj Tangcharoensathien (email: <email xlink:href="viroj@ihpp.thaigov.net">viroj@ihpp.thaigov.net</email>).</corresp></author-notes><pub-date pub-type="ppub"><day>01</day><month>2</month><year>2019</year></pub-date><pub-date pub-type="epub"><day>19</day><month>12</month><year>2018</year></pub-date><volume>97</volume><issue>2</issue><fpage>129</fpage><lpage>141</lpage><history><date date-type="received"><day>15</day><month>7</month><year>2018</year></date><date date-type="rev-recd"><day>06</day><month>11</month><year>2018</year></date><date date-type="accepted"><day>13</day><month>11</month><year>2018</year></date></history><permissions><copyright-statement>(c) 2018 The authors; licensee World Health Organization.</copyright-statement><copyright-year>2018</copyright-year><license license-type="open-access"><license-p>This is an open access article distributed under the terms of the Creative Commons Attribution IGO License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0/igo/legalcode">http://creativecommons.org/licenses/by/3.0/igo/legalcode</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. In any reproduction of this article there should not be any suggestion that WHO or this article endorse any specific organization or products. The use of the WHO logo is not permitted. This notice should be preserved along with the article's original URL.</license-p></license></permissions><abstract><title>Abstract</title><p>By 2016, Member States of the World Health Organization (WHO) had developed and implemented national action plans on noncommunicable diseases in line with the <italic>Global action plan for the prevention and control of noncommunicable diseases (2013&#x02013;2020).</italic> In 2018, we assessed the implementation status of the recommended best-buy noncommunicable diseases interventions in seven Asian countries: Bhutan, Cambodia, Indonesia, Philippines, Sri Lanka, Thailand and Viet Nam. We gathered data from a range of published reports and directly from health ministries. We included interventions that addressed the use of tobacco and alcohol, inadequate physical activity and high salt intake, as well as health-systems responses, and we identified gaps and proposed solutions. In 2018, progress was uneven across countries. Implementation gaps were largely due to inadequate funding; limited institutional capacity (despite designated noncommunicable diseases units); inadequate action across different sectors within and outside the health system; and a lack of standardized monitoring and evaluation mechanisms to inform policies. To address implementation gaps, governments need to invest more in effective interventions such as the WHO-recommended best-buy interventions, improve action across different sectors, and enhance capacity in monitoring and evaluation and in research. Learning from the Framework Convention on Tobacco Control, the WHO and international partners should develop a standardized, comprehensive monitoring tool on alcohol, salt and unhealthy food consumption, physical activity and health-systems response.</p></abstract><trans-abstract xml:lang="fr"><title>R&#x000e9;sum&#x000e9;</title><p>En 2016, les &#x000c9;tats membres de l'Organisation mondiale de la Sant&#x000e9; (OMS) avaient &#x000e9;labor&#x000e9; et mis en &#x00153;uvre des plans d'action nationaux sur les maladies non transmissibles conform&#x000e9;ment au Plan d'action mondial pour la lutte contre les maladies non transmissibles (2013&#x02013;2020). En 2018, nous avons &#x000e9;valu&#x000e9; l'&#x000e9;tat de l'application des interventions les plus avantageuses recommand&#x000e9;es en mati&#x000e8;re de maladies non transmissibles dans sept pays asiatiques: le Bhoutan, le Cambodge, l'Indon&#x000e9;sie, les Philippines, le Sri Lanka, la Tha&#x000ef;lande et le Viet Nam. Nous avons recueilli des donn&#x000e9;es &#x000e0; partir de toute une s&#x000e9;rie de rapports publi&#x000e9;s et directement aupr&#x000e8;s des minist&#x000e8;res de la Sant&#x000e9;. Nous avons inclus les interventions qui concernaient la consommation de tabac et d'alcool, une activit&#x000e9; physique inad&#x000e9;quate et une consommation de sel &#x000e9;lev&#x000e9;e, ainsi que les r&#x000e9;ponses des syst&#x000e8;mes de sant&#x000e9;, et nous avons identifi&#x000e9; les lacunes et propos&#x000e9; des solutions. En 2018, les progr&#x000e8;s &#x000e9;taient variables selon les pays. Les lacunes &#x000e9;taient largement dues &#x000e0; un financement inad&#x000e9;quat; des capacit&#x000e9;s institutionnelles limit&#x000e9;es (malgr&#x000e9; des unit&#x000e9;s d&#x000e9;di&#x000e9;es aux maladies non transmissibles); une action inad&#x000e9;quate dans les diff&#x000e9;rents secteurs au sein et en dehors du syst&#x000e8;me de sant&#x000e9;; et l'absence de m&#x000e9;canismes de suivi et d'&#x000e9;valuation standardis&#x000e9;s pour orienter les politiques. Afin de combler ces lacunes, les gouvernements doivent investir davantage dans des interventions efficaces telles que les interventions les plus avantageuses recommand&#x000e9;es par l'OMS, am&#x000e9;liorer l'action dans les diff&#x000e9;rents secteurs, et renforcer les capacit&#x000e9;s en mati&#x000e8;re de suivi et d'&#x000e9;valuation, mais aussi de recherche. En s'inspirant de la Convention-cadre pour la lutte antitabac, l'OMS et ses partenaires internationaux devraient &#x000e9;laborer un outil de suivi complet et standardis&#x000e9; sur la consommation d'alcool, de sel et d'aliments malsains, l'activit&#x000e9; physique et la r&#x000e9;ponse des syst&#x000e8;mes de sant&#x000e9;.</p></trans-abstract><trans-abstract xml:lang="es"><title>Resumen</title><p>Para 2016, los Estados miembros de la Organizaci&#x000f3;n Mundial de la Salud (OMS) hab&#x000ed;an elaborado y aplicado planes de acci&#x000f3;n nacionales sobre las enfermedades no contagiosas de acuerdo con el Plan de acci&#x000f3;n mundial para la prevenci&#x000f3;n y el control de las enfermedades no transmisibles (2013-2020). En 2018, se evalu&#x000f3; el estado de implementaci&#x000f3;n de las intervenciones recomendadas en siete pa&#x000ed;ses asi&#x000e1;ticos en materia de enfermedades no contagiosas: Bhut&#x000e1;n, Camboya, Filipinas, Indonesia, Sri Lanka, Tailandia y Vietnam. Se recopilaron datos de una serie de informes publicados y directamente de los ministerios de salud. Se incluyeron intervenciones que abordaron el uso del tabaco y el alcohol, la actividad f&#x000ed;sica inadecuada y la ingesta elevada de sal, as&#x000ed; como las respuestas de los sistemas de salud, se identificaron las deficiencias y se propusieron soluciones. En 2018, el progreso fue desigual entre los pa&#x000ed;ses. Las deficiencias en la aplicaci&#x000f3;n se debieron en gran medida a la falta de financiaci&#x000f3;n, a la limitada capacidad institucional (a pesar de las dependencias designadas para las enfermedades no contagiosas), a la inadecuaci&#x000f3;n de las medidas adoptadas en los diferentes sectores dentro y fuera del sistema de salud y a la falta de mecanismos normalizados de supervisi&#x000f3;n y evaluaci&#x000f3;n que sirvieran de base a las pol&#x000ed;ticas. Para subsanar las deficiencias en materia de aplicaci&#x000f3;n, los gobiernos deben invertir m&#x000e1;s en intervenciones eficaces, como las recomendadas por la OMS, mejorar las medidas adoptadas en los distintos sectores y aumentar la capacidad de seguimiento y evaluaci&#x000f3;n y de investigaci&#x000f3;n. A partir de las ense&#x000f1;anzas del Convenio Marco para el Control del Tabaco, la OMS y los asociados internacionales deber&#x000ed;an elaborar un instrumento de seguimiento normalizado y completo para el consumo de alcohol, sal y alimentos no saludables, la actividad f&#x000ed;sica y la respuesta de los sistemas de salud.</p></trans-abstract><trans-abstract xml:lang="ar"><title>&#x00645;&#x00644;&#x0062e;&#x00635; </title><p>&#x00642;&#x00627;&#x00645;&#x0062a; &#x00627;&#x00644;&#x0062f;&#x00648;&#x00644; &#x00627;&#x00644;&#x00623;&#x00639;&#x00636;&#x00627;&#x00621; &#x00641;&#x0064a; &#x00645;&#x00646;&#x00638;&#x00645;&#x00629; &#x00627;&#x00644;&#x00635;&#x0062d;&#x00629; &#x00627;&#x00644;&#x00639;&#x00627;&#x00644;&#x00645;&#x0064a;&#x00629; (WHO) &#x00641;&#x0064a; &#x00639;&#x00627;&#x00645; 2016 &#x00628;&#x0062a;&#x00637;&#x00648;&#x0064a;&#x00631; &#x00648;&#x0062a;&#x00646;&#x00641;&#x0064a;&#x00630; &#x0062e;&#x00637;&#x00637; &#x00639;&#x00645;&#x00644; &#x00648;&#x00637;&#x00646;&#x0064a;&#x00629; &#x00628;&#x00634;&#x00623;&#x00646; &#x00627;&#x00644;&#x00623;&#x00645;&#x00631;&#x00627;&#x00636; &#x0063a;&#x0064a;&#x00631; &#x00627;&#x00644;&#x00645;&#x00639;&#x0062f;&#x0064a;&#x00629; &#x00628;&#x00645;&#x00627; &#x0064a;&#x0062a;&#x00645;&#x00627;&#x00634;&#x00649; &#x00645;&#x00639; &#x0062e;&#x00637;&#x00629; &#x00627;&#x00644;&#x00639;&#x00645;&#x00644; &#x00627;&#x00644;&#x00639;&#x00627;&#x00644;&#x00645;&#x0064a;&#x00629; &#x00644;&#x00644;&#x00648;&#x00642;&#x00627;&#x0064a;&#x00629; &#x00645;&#x00646; &#x00627;&#x00644;&#x00623;&#x00645;&#x00631;&#x00627;&#x00636; &#x0063a;&#x0064a;&#x00631; &#x00627;&#x00644;&#x00645;&#x00639;&#x0062f;&#x0064a;&#x00629; &#x00648;&#x00645;&#x00643;&#x00627;&#x00641;&#x0062d;&#x0062a;&#x00647;&#x00627; (2013-2020). &#x00641;&#x0064a; &#x00639;&#x00627;&#x00645; 2018&#x0060c; &#x00642;&#x00645;&#x00646;&#x00627; &#x00628;&#x0062a;&#x00642;&#x0064a;&#x0064a;&#x00645; &#x0062d;&#x00627;&#x00644;&#x00629; &#x0062a;&#x00646;&#x00641;&#x0064a;&#x00630; &#x00623;&#x00641;&#x00636;&#x00644; &#x00627;&#x00644;&#x0062a;&#x0062f;&#x0062e;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00645;&#x00648;&#x00635;&#x00649; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00623;&#x00645;&#x00631;&#x00627;&#x00636; &#x0063a;&#x0064a;&#x00631; &#x00627;&#x00644;&#x00645;&#x00639;&#x0062f;&#x0064a;&#x00629; &#x00641;&#x0064a; &#x00633;&#x00628;&#x00639;&#x00629; &#x00628;&#x00644;&#x0062f;&#x00627;&#x00646; &#x00622;&#x00633;&#x0064a;&#x00648;&#x0064a;&#x00629;: &#x00625;&#x00646;&#x0062f;&#x00648;&#x00646;&#x0064a;&#x00633;&#x0064a;&#x00627; &#x00648;&#x00627;&#x00644;&#x00641;&#x00644;&#x00628;&#x0064a;&#x00646; &#x00648;&#x00628;&#x00648;&#x0062a;&#x00627;&#x00646; &#x00648;&#x0062a;&#x00627;&#x0064a;&#x00644;&#x00646;&#x0062f; &#x00648;&#x00633;&#x00631;&#x0064a; &#x00644;&#x00627;&#x00646;&#x00643;&#x00627; &#x00648;&#x00641;&#x0064a;&#x0064a;&#x0062a; &#x00646;&#x00627;&#x00645; &#x00648;&#x00643;&#x00645;&#x00628;&#x00648;&#x0062f;&#x0064a;&#x00627;. &#x00642;&#x00645;&#x00646;&#x00627; &#x00628;&#x0062c;&#x00645;&#x00639; &#x00628;&#x0064a;&#x00627;&#x00646;&#x00627;&#x0062a; &#x00645;&#x00646; &#x00645;&#x0062c;&#x00645;&#x00648;&#x00639;&#x00629; &#x00645;&#x00646; &#x00627;&#x00644;&#x0062a;&#x00642;&#x00627;&#x00631;&#x0064a;&#x00631; &#x00627;&#x00644;&#x00645;&#x00646;&#x00634;&#x00648;&#x00631;&#x00629;&#x0060c; &#x00643;&#x00645;&#x00627; &#x0062c;&#x00645;&#x00639;&#x00646;&#x00627; &#x00627;&#x00644;&#x00628;&#x0064a;&#x00627;&#x00646;&#x00627;&#x0062a; &#x00645;&#x00628;&#x00627;&#x00634;&#x00631;&#x00629; &#x00645;&#x00646; &#x00648;&#x00632;&#x00627;&#x00631;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00635;&#x0062d;&#x00629;. &#x00648;&#x00642;&#x00645;&#x00646;&#x00627; &#x00628;&#x0062a;&#x00636;&#x00645;&#x0064a;&#x00646; &#x00627;&#x00644;&#x0062a;&#x0062f;&#x0062e;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062a;&#x0064a; &#x0062a;&#x00646;&#x00627;&#x00648;&#x00644;&#x0062a; &#x00627;&#x00633;&#x0062a;&#x0062e;&#x0062f;&#x00627;&#x00645; &#x00627;&#x00644;&#x0062a;&#x00628;&#x0063a; &#x00648;&#x00627;&#x00644;&#x00643;&#x0062d;&#x00648;&#x00644;&#x0060c; &#x00648;&#x00627;&#x00644;&#x00646;&#x00634;&#x00627;&#x00637; &#x00627;&#x00644;&#x00628;&#x0062f;&#x00646;&#x0064a; &#x0063a;&#x0064a;&#x00631; &#x00627;&#x00644;&#x00643;&#x00627;&#x00641;&#x0064a; &#x00648;&#x00627;&#x00644;&#x00627;&#x00633;&#x0062a;&#x00647;&#x00644;&#x00627;&#x00643; &#x00627;&#x00644;&#x00645;&#x00631;&#x0062a;&#x00641;&#x00639; &#x00645;&#x00646; &#x00627;&#x00644;&#x00645;&#x00644;&#x0062d;&#x0060c; &#x00648;&#x00643;&#x00630;&#x00644;&#x00643; &#x00627;&#x00633;&#x0062a;&#x0062c;&#x00627;&#x00628;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00623;&#x00646;&#x00638;&#x00645;&#x00629; &#x00627;&#x00644;&#x00635;&#x0062d;&#x0064a;&#x00629;&#x0060c; &#x00648;&#x0062d;&#x0062f;&#x0062f;&#x00646;&#x00627; &#x00627;&#x00644;&#x00641;&#x0062c;&#x00648;&#x00627;&#x0062a; &#x00648;&#x00627;&#x00644;&#x0062d;&#x00644;&#x00648;&#x00644; &#x00627;&#x00644;&#x00645;&#x00642;&#x0062a;&#x00631;&#x0062d;&#x00629;. &#x00648;&#x00641;&#x0064a; &#x00639;&#x00627;&#x00645; 2018&#x0060c; &#x00643;&#x00627;&#x00646; &#x00627;&#x00644;&#x0062a;&#x00642;&#x0062f;&#x00645; &#x00645;&#x0062a;&#x00641;&#x00627;&#x00648;&#x0062a;&#x00627; &#x00628;&#x0064a;&#x00646; &#x00627;&#x00644;&#x00628;&#x00644;&#x0062f;&#x00627;&#x00646;. &#x00648;&#x00643;&#x00627;&#x00646;&#x0062a; &#x00627;&#x00644;&#x00641;&#x0062c;&#x00648;&#x00627;&#x0062a; &#x00641;&#x0064a; &#x00645;&#x00633;&#x0062a;&#x00648;&#x00649; &#x00627;&#x00644;&#x0062a;&#x00646;&#x00641;&#x0064a;&#x00630; &#x0062a;&#x00631;&#x0062c;&#x00639; &#x00625;&#x00644;&#x00649; &#x0062d;&#x0062f; &#x00643;&#x00628;&#x0064a;&#x00631; &#x00625;&#x00644;&#x00649; &#x00639;&#x0062f;&#x00645; &#x00643;&#x00641;&#x00627;&#x0064a;&#x00629; &#x00627;&#x00644;&#x0062a;&#x00645;&#x00648;&#x0064a;&#x00644;&#x0061b; &#x00648;&#x00627;&#x00644;&#x00642;&#x0062f;&#x00631;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00645;&#x00624;&#x00633;&#x00633;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00645;&#x0062d;&#x0062f;&#x00648;&#x0062f;&#x00629; (&#x00639;&#x00644;&#x00649; &#x00627;&#x00644;&#x00631;&#x0063a;&#x00645; &#x00645;&#x00646; &#x00627;&#x00644;&#x00648;&#x0062d;&#x0062f;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00645;&#x0062e;&#x00635;&#x00635;&#x00629; &#x00644;&#x00644;&#x00623;&#x00645;&#x00631;&#x00627;&#x00636; &#x0063a;&#x0064a;&#x00631; &#x00627;&#x00644;&#x00633;&#x00627;&#x00631;&#x0064a;&#x00629;)&#x0061b; &#x00648;&#x00639;&#x0062f;&#x00645; &#x00643;&#x00641;&#x00627;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00639;&#x00645;&#x00644; &#x00639;&#x00628;&#x00631; &#x00627;&#x00644;&#x00642;&#x00637;&#x00627;&#x00639;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00645;&#x0062e;&#x0062a;&#x00644;&#x00641;&#x00629; &#x0062f;&#x00627;&#x0062e;&#x00644; &#x00648;&#x0062e;&#x00627;&#x00631;&#x0062c; &#x00627;&#x00644;&#x00646;&#x00638;&#x00627;&#x00645; &#x00627;&#x00644;&#x00635;&#x0062d;&#x0064a;&#x0061b; &#x00648;&#x00639;&#x0062f;&#x00645; &#x00648;&#x0062c;&#x00648;&#x0062f; &#x00622;&#x00644;&#x0064a;&#x00627;&#x0062a; &#x00645;&#x00648;&#x0062d;&#x0062f;&#x00629; &#x00644;&#x00644;&#x00631;&#x00635;&#x0062f; &#x00648;&#x00627;&#x00644;&#x0062a;&#x00642;&#x0064a;&#x0064a;&#x00645; &#x00644;&#x0062a;&#x00648;&#x0062c;&#x0064a;&#x00647; &#x00627;&#x00644;&#x00633;&#x0064a;&#x00627;&#x00633;&#x00627;&#x0062a;. &#x00648;&#x00644;&#x00645;&#x00639;&#x00627;&#x00644;&#x0062c;&#x00629; &#x00627;&#x00644;&#x00641;&#x0062c;&#x00648;&#x00627;&#x0062a; &#x00639;&#x00644;&#x00649; &#x00645;&#x00633;&#x0062a;&#x00648;&#x00649; &#x00627;&#x00644;&#x0062a;&#x00646;&#x00641;&#x0064a;&#x00630;&#x0060c; &#x0062a;&#x0062d;&#x0062a;&#x00627;&#x0062c; &#x00627;&#x00644;&#x0062d;&#x00643;&#x00648;&#x00645;&#x00627;&#x0062a; &#x00625;&#x00644;&#x00649; &#x00623;&#x00646; &#x0062a;&#x00633;&#x0062a;&#x0062b;&#x00645;&#x00631; &#x00623;&#x00643;&#x0062b;&#x00631; &#x00641;&#x0064a; &#x00627;&#x00644;&#x0062a;&#x0062f;&#x0062e;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x00641;&#x00639;&#x00627;&#x00644;&#x00629; &#x00645;&#x0062b;&#x00644; &#x00623;&#x00641;&#x00636;&#x00644; &#x00627;&#x00644;&#x0062a;&#x0062f;&#x0062e;&#x00644;&#x00627;&#x0062a; &#x00627;&#x00644;&#x0062a;&#x0064a; &#x0062a;&#x00648;&#x00635;&#x00649; &#x00628;&#x00647;&#x00627; &#x00645;&#x00646;&#x00638;&#x00645;&#x00629; &#x00627;&#x00644;&#x00635;&#x0062d;&#x00629; &#x00627;&#x00644;&#x00639;&#x00627;&#x00644;&#x00645;&#x0064a;&#x00629;&#x0060c; &#x00648;&#x0062a;&#x0062d;&#x00633;&#x0064a;&#x00646; &#x00627;&#x00644;&#x00639;&#x00645;&#x00644; &#x00639;&#x00628;&#x00631; &#x00645;&#x0062e;&#x0062a;&#x00644;&#x00641; &#x00627;&#x00644;&#x00642;&#x00637;&#x00627;&#x00639;&#x00627;&#x0062a;&#x0060c; &#x00648;&#x0062a;&#x00639;&#x00632;&#x0064a;&#x00632; &#x00627;&#x00644;&#x00642;&#x0062f;&#x00631;&#x00629; &#x00639;&#x00644;&#x00649; &#x00627;&#x00644;&#x00631;&#x00635;&#x0062f; &#x00648;&#x00627;&#x00644;&#x0062a;&#x00642;&#x0064a;&#x0064a;&#x00645; &#x00641;&#x0064a; &#x00627;&#x00644;&#x00623;&#x00628;&#x0062d;&#x00627;&#x0062b;. &#x00628;&#x00646;&#x00627;&#x00621; &#x00639;&#x00644;&#x00649; &#x00627;&#x00644;&#x00627;&#x00633;&#x0062a;&#x00641;&#x00627;&#x0062f;&#x00629; &#x00627;&#x00644;&#x00645;&#x0062d;&#x00642;&#x00642;&#x00629; &#x00645;&#x00646; &#x00627;&#x00644;&#x00627;&#x0062a;&#x00641;&#x00627;&#x00642;&#x0064a;&#x00629; &#x00627;&#x00644;&#x00625;&#x00637;&#x00627;&#x00631;&#x0064a;&#x00629; &#x00644;&#x00645;&#x00643;&#x00627;&#x00641;&#x0062d;&#x00629; &#x00627;&#x00644;&#x0062a;&#x00628;&#x0063a;&#x0060c; &#x00641;&#x00625;&#x00646;&#x00647; &#x0064a;&#x0062c;&#x00628; &#x00639;&#x00644;&#x00649; &#x00643;&#x00644; &#x00645;&#x00646; &#x00645;&#x00646;&#x00638;&#x00645;&#x00629; &#x00627;&#x00644;&#x00635;&#x0062d;&#x00629; &#x00627;&#x00644;&#x00639;&#x00627;&#x00644;&#x00645;&#x0064a;&#x00629; &#x00648;&#x00627;&#x00644;&#x00634;&#x00631;&#x00643;&#x00627;&#x00621; &#x00627;&#x00644;&#x0062f;&#x00648;&#x00644;&#x0064a;&#x0064a;&#x00646; &#x0062a;&#x00637;&#x00648;&#x0064a;&#x00631; &#x00623;&#x0062f;&#x00627;&#x00629; &#x00631;&#x00635;&#x0062f; &#x00642;&#x0064a;&#x00627;&#x00633;&#x0064a;&#x00629; &#x00648;&#x00634;&#x00627;&#x00645;&#x00644;&#x00629; &#x00644;&#x00643;&#x00644; &#x00645;&#x00646; &#x00627;&#x00644;&#x00643;&#x0062d;&#x00648;&#x00644; &#x00648;&#x00627;&#x00644;&#x00645;&#x00644;&#x0062d; &#x00648;&#x00627;&#x00644;&#x00627;&#x00633;&#x0062a;&#x00647;&#x00644;&#x00627;&#x00643; &#x00627;&#x00644;&#x0063a;&#x00630;&#x00627;&#x00626;&#x0064a; &#x0063a;&#x0064a;&#x00631; &#x00627;&#x00644;&#x00635;&#x0062d;&#x0064a; &#x00648;&#x00627;&#x00644;&#x00646;&#x00634;&#x00627;&#x00637; &#x00627;&#x00644;&#x00628;&#x0062f;&#x00646;&#x0064a; &#x00648;&#x00627;&#x00633;&#x0062a;&#x0062c;&#x00627;&#x00628;&#x00629; &#x00627;&#x00644;&#x00646;&#x00638;&#x00645; &#x00627;&#x00644;&#x00635;&#x0062d;&#x0064a;&#x00629;. </p></trans-abstract><trans-abstract xml:lang="zh"><title>&#x06458;&#x08981;</title><p>&#x0622a;&#x081f3; 2016 &#x05e74;&#x0ff0c;&#x04e16;&#x0754c;&#x0536b;&#x0751f;&#x07ec4;&#x07ec7; (WHO) &#x06210;&#x05458;&#x056fd;&#x05747;&#x05df2;&#x06839;&#x0636e;&#x0300a;&#x09884;&#x09632;&#x0548c;&#x063a7;&#x05236;&#x0975e;&#x04f20;&#x067d3;&#x06027;&#x075be;&#x075c5;&#x05168;&#x07403;&#x0884c;&#x052a8;&#x08ba1;&#x05212; (2013-2020)&#x0300b;&#x05f00;&#x05c55;&#x05e76;&#x05b9e;&#x065bd;&#x04e86;&#x0975e;&#x04f20;&#x067d3;&#x06027;&#x075be;&#x075c5;&#x056fd;&#x05bb6;&#x0884c;&#x052a8;&#x08ba1;&#x05212;&#x03002;2018 &#x05e74;&#x0ff0c;&#x06211;&#x04eec;&#x08bc4;&#x04f30;&#x04e86;&#x04e9a;&#x06d32;&#x04e03;&#x056fd;&#x09884;&#x09632;&#x0548c;&#x063a7;&#x05236;&#x0975e;&#x04f20;&#x067d3;&#x06027;&#x075be;&#x075c5;&#x07684;&#x0201c;&#x06700;&#x05408;&#x07b97;&#x063aa;&#x065bd;&#x0201d;&#x04ee5;&#x053ca;&#x05176;&#x05b83;&#x063a8;&#x08350;&#x05e72;&#x09884;&#x063aa;&#x065bd;&#x07684;&#x05b9e;&#x065bd;&#x060c5;&#x051b5;&#x03002;&#x08fd9;&#x04e03;&#x04e2a;&#x056fd;&#x05bb6;&#x05206;&#x0522b;&#x0662f;&#x0ff1a;&#x04e0d;&#x04e39;&#x03001;&#x083f2;&#x05f8b;&#x05bbe;&#x03001;&#x067ec;&#x057d4;&#x05be8;&#x03001;&#x065af;&#x091cc;&#x05170;&#x05361;&#x03001;&#x06cf0;&#x056fd;&#x03001;&#x05370;&#x05ea6;&#x05c3c;&#x0897f;&#x04e9a;&#x03001;&#x0548c;&#x08d8a;&#x05357;&#x03002;&#x06211;&#x04eec;&#x04ece;&#x04e00;&#x07cfb;&#x05217;&#x05df2;&#x053d1;&#x08868;&#x07684;&#x062a5;&#x0544a;&#x0548c;&#x0536b;&#x0751f;&#x090e8;&#x095e8;&#x076f4;&#x063a5;&#x06536;&#x096c6;&#x06570;&#x0636e;&#x03002;&#x08c03;&#x067e5;&#x06db5;&#x076d6;&#x04e86;&#x051cf;&#x05c11;&#x070df;&#x08349;&#x04f7f;&#x07528;&#x03001;&#x051cf;&#x05c11;&#x06709;&#x05bb3;&#x04f7f;&#x07528;&#x09152;&#x07cbe;&#x03001;&#x051cf;&#x05c11;&#x08eab;&#x04f53;&#x04e0d;&#x08db3;&#x06d3b;&#x052a8;&#x03001;&#x051cf;&#x05c11;&#x09ad8;&#x076d0;&#x06444;&#x05165;&#x07b49;&#x05e72;&#x09884;&#x063aa;&#x065bd;&#x0ff0c;&#x0540c;&#x065f6;&#x08fd8;&#x06709;&#x0536b;&#x0751f;&#x07cfb;&#x07edf;&#x053cd;&#x05e94;&#x0ff0c;&#x06211;&#x04eec;&#x07531;&#x06b64;&#x0786e;&#x05b9a;&#x05b9e;&#x065bd;&#x07684;&#x05dee;&#x08ddd;&#x0ff0c;&#x05e76;&#x063d0;&#x051fa;&#x089e3;&#x051b3;&#x065b9;&#x06848;&#x03002;2018 &#x05e74;&#x0ff0c;&#x05404;&#x056fd;&#x05728;&#x06b64;&#x065b9;&#x09762;&#x07684;&#x08fdb;&#x05c55;&#x05e76;&#x04e0d;&#x05747;&#x08861;&#x03002;&#x05e72;&#x09884;&#x063aa;&#x065bd;&#x07684;&#x05b9e;&#x065bd;&#x05b58;&#x05728;&#x05dee;&#x08ddd;&#x07684;&#x04e3b;&#x08981;&#x0539f;&#x056e0;&#x05305;&#x062ec;&#x08d44;&#x091d1;&#x04e0d;&#x08db3;&#x0ff1b;&#x0673a;&#x06784;&#x080fd;&#x0529b;&#x06709;&#x09650;&#x0ff08;&#x05c3d;&#x07ba1;&#x06307;&#x06d3e;&#x04e86;&#x0975e;&#x04f20;&#x067d3;&#x06027;&#x075be;&#x075c5;&#x090e8;&#x095e8;&#x0ff09;&#x0ff1b;&#x0536b;&#x0751f;&#x07cfb;&#x07edf;&#x05185;&#x05916;&#x04e0d;&#x0540c;&#x090e8;&#x095e8;&#x07684;&#x0884c;&#x052a8;&#x04e0d;&#x08db3;&#x0ff1b;&#x04ee5;&#x053ca;&#x07f3a;&#x04e4f;&#x05236;&#x05b9a;&#x0653f;&#x07b56;&#x07684;&#x06807;&#x051c6;&#x05316;&#x076d1;&#x06d4b;&#x0548c;&#x08bc4;&#x04f30;&#x0673a;&#x05236;&#x03002;&#x04e3a;&#x04e86;&#x089e3;&#x051b3;&#x05b9e;&#x065bd;&#x05dee;&#x08ddd;&#x0ff0c;&#x0653f;&#x05e9c;&#x05e94;&#x066f4;&#x0591a;&#x05730;&#x091c7;&#x053d6;&#x06709;&#x06548;&#x07684;&#x05e72;&#x09884;&#x063aa;&#x065bd;&#x0ff0c;&#x04f8b;&#x05982;&#x04e16;&#x0754c;&#x0536b;&#x0751f;&#x07ec4;&#x07ec7;&#x09884;&#x09632;&#x0548c;&#x063a7;&#x05236;&#x0975e;&#x04f20;&#x067d3;&#x06027;&#x075be;&#x075c5;&#x07684;&#x0201c;&#x06700;&#x05408;&#x07b97;&#x063aa;&#x065bd;&#x0201d;&#x04ee5;&#x053ca;&#x05176;&#x05b83;&#x063a8;&#x08350;&#x05e72;&#x09884;&#x063aa;&#x065bd;&#x0ff0c;&#x04ece;&#x0800c;&#x06539;&#x05584;&#x04e0d;&#x0540c;&#x090e8;&#x095e8;&#x07684;&#x0884c;&#x052a8;&#x0529b;&#x0ff0c;&#x063d0;&#x09ad8;&#x076d1;&#x06d4b;&#x03001;&#x08bc4;&#x04f30;&#x0548c;&#x07814;&#x07a76;&#x07684;&#x080fd;&#x0529b;&#x03002;&#x06839;&#x0636e;&#x0300a;&#x070df;&#x08349;&#x063a7;&#x05236;&#x06846;&#x067b6;&#x0516c;&#x07ea6;&#x0300b;&#x0ff0c;&#x04e16;&#x0536b;&#x07ec4;&#x07ec7;&#x053ca;&#x05176;&#x056fd;&#x09645;&#x05408;&#x04f5c;&#x04f19;&#x04f34;&#x05e94;&#x05236;&#x05b9a;&#x05173;&#x04e8e;&#x09152;&#x07cbe;&#x03001;&#x076d0;&#x0548c;&#x04e0d;&#x05065;&#x05eb7;&#x0996e;&#x098df;&#x03001;&#x08eab;&#x04f53;&#x06d3b;&#x052a8;&#x04e0d;&#x08db3;&#x0548c;&#x0536b;&#x0751f;&#x07cfb;&#x07edf;&#x053cd;&#x05e94;&#x07684;&#x06807;&#x051c6;&#x05316;&#x07efc;&#x05408;&#x076d1;&#x06d4b;&#x05de5;&#x05177;&#x03002;</p></trans-abstract><trans-abstract xml:lang="ru"><title>&#x00420;&#x00435;&#x00437;&#x0044e;&#x0043c;&#x00435;</title><p>&#x0041a; 2016&#x000a0;&#x00433;&#x0043e;&#x00434;&#x00443; &#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x0044b;-&#x00447;&#x0043b;&#x00435;&#x0043d;&#x0044b; &#x00412;&#x00441;&#x00435;&#x0043c;&#x00438;&#x00440;&#x0043d;&#x0043e;&#x00439; &#x0043e;&#x00440;&#x00433;&#x00430;&#x0043d;&#x00438;&#x00437;&#x00430;&#x00446;&#x00438;&#x00438; &#x00437;&#x00434;&#x00440;&#x00430;&#x00432;&#x0043e;&#x0043e;&#x00445;&#x00440;&#x00430;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x0044f;&#x000a0;(&#x00412;&#x0041e;&#x00417;) &#x00440;&#x00430;&#x00437;&#x00440;&#x00430;&#x00431;&#x0043e;&#x00442;&#x00430;&#x0043b;&#x00438; &#x00438; &#x0043e;&#x00441;&#x00443;&#x00449;&#x00435;&#x00441;&#x00442;&#x00432;&#x00438;&#x0043b;&#x00438; &#x0043d;&#x00430;&#x00446;&#x00438;&#x0043e;&#x0043d;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x00435; &#x0043f;&#x0043b;&#x00430;&#x0043d;&#x0044b; &#x00434;&#x00435;&#x00439;&#x00441;&#x00442;&#x00432;&#x00438;&#x00439; &#x00432; &#x0043e;&#x00442;&#x0043d;&#x0043e;&#x00448;&#x00435;&#x0043d;&#x00438;&#x00438; &#x0043d;&#x00435;&#x00438;&#x0043d;&#x00444;&#x00435;&#x0043a;&#x00446;&#x00438;&#x0043e;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x00437;&#x00430;&#x00431;&#x0043e;&#x0043b;&#x00435;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00439; &#x00432; &#x00441;&#x0043e;&#x0043e;&#x00442;&#x00432;&#x00435;&#x00442;&#x00441;&#x00442;&#x00432;&#x00438;&#x00438; &#x00441; &#x0041c;&#x00438;&#x00440;&#x0043e;&#x00432;&#x0044b;&#x0043c; &#x0043f;&#x0043b;&#x00430;&#x0043d;&#x0043e;&#x0043c; &#x00434;&#x00435;&#x00439;&#x00441;&#x00442;&#x00432;&#x00438;&#x00439; &#x0043f;&#x0043e; &#x0043f;&#x00440;&#x00435;&#x00434;&#x0043e;&#x00442;&#x00432;&#x00440;&#x00430;&#x00449;&#x00435;&#x0043d;&#x00438;&#x0044e; &#x00438; &#x0043a;&#x0043e;&#x0043d;&#x00442;&#x00440;&#x0043e;&#x0043b;&#x0044e; &#x00440;&#x00430;&#x00441;&#x0043f;&#x00440;&#x0043e;&#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x0043d;&#x00435;&#x00438;&#x0043d;&#x00444;&#x00435;&#x0043a;&#x00446;&#x00438;&#x0043e;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x00437;&#x00430;&#x00431;&#x0043e;&#x0043b;&#x00435;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00439;&#x000a0;(2013&#x02013;2020&#x000a0;&#x00433;&#x00433;.). &#x00412; 2018&#x000a0;&#x00433;&#x0043e;&#x00434;&#x00443; &#x00431;&#x0044b;&#x0043b;&#x00430; &#x0043f;&#x00440;&#x0043e;&#x00432;&#x00435;&#x00434;&#x00435;&#x0043d;&#x00430; &#x0043e;&#x00446;&#x00435;&#x0043d;&#x0043a;&#x00430; &#x00441;&#x0043e;&#x00441;&#x00442;&#x0043e;&#x0044f;&#x0043d;&#x00438;&#x0044f; &#x00440;&#x00435;&#x0043a;&#x0043e;&#x0043c;&#x00435;&#x0043d;&#x00434;&#x00443;&#x00435;&#x0043c;&#x0044b;&#x00445; &#x00438; &#x0043d;&#x00430;&#x00438;&#x00431;&#x0043e;&#x0043b;&#x00435;&#x00435; &#x0043f;&#x0043e;&#x0043f;&#x00443;&#x0043b;&#x0044f;&#x00440;&#x0043d;&#x0044b;&#x00445; &#x0043c;&#x00435;&#x00440; &#x00431;&#x0043e;&#x00440;&#x0044c;&#x00431;&#x0044b; &#x00441; &#x0043d;&#x00435;&#x00438;&#x0043d;&#x00444;&#x00435;&#x0043a;&#x00446;&#x00438;&#x0043e;&#x0043d;&#x0043d;&#x0044b;&#x0043c;&#x00438; &#x00437;&#x00430;&#x00431;&#x0043e;&#x0043b;&#x00435;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f;&#x0043c;&#x00438; &#x00432; &#x00441;&#x00435;&#x0043c;&#x00438; &#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00430;&#x00445; &#x00410;&#x00437;&#x00438;&#x00438;: &#x00432; &#x00411;&#x00443;&#x00442;&#x00430;&#x0043d;&#x00435;, &#x00412;&#x0044c;&#x00435;&#x00442;&#x0043d;&#x00430;&#x0043c;&#x00435;, &#x00418;&#x0043d;&#x00434;&#x0043e;&#x0043d;&#x00435;&#x00437;&#x00438;&#x00438;, &#x0041a;&#x00430;&#x0043c;&#x00431;&#x0043e;&#x00434;&#x00436;&#x00435;, &#x00422;&#x00430;&#x00438;&#x0043b;&#x00430;&#x0043d;&#x00434;&#x00435;, &#x0043d;&#x00430; &#x00424;&#x00438;&#x0043b;&#x00438;&#x0043f;&#x0043f;&#x00438;&#x0043d;&#x00430;&#x00445; &#x00438; &#x00432; &#x00428;&#x00440;&#x00438;-&#x0041b;&#x00430;&#x0043d;&#x0043a;&#x00435;. &#x00411;&#x0044b;&#x0043b;&#x00438; &#x00441;&#x0043e;&#x00431;&#x00440;&#x00430;&#x0043d;&#x0044b; &#x00434;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00435; &#x00440;&#x0044f;&#x00434;&#x00430; &#x0043e;&#x0043f;&#x00443;&#x00431;&#x0043b;&#x00438;&#x0043a;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043e;&#x00442;&#x00447;&#x00435;&#x00442;&#x0043e;&#x00432;, &#x00430; &#x00442;&#x00430;&#x0043a;&#x00436;&#x00435; &#x0043f;&#x0043e;&#x0043b;&#x00443;&#x00447;&#x00435;&#x0043d;&#x0044b; &#x00441;&#x00432;&#x00435;&#x00434;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x0043d;&#x00435;&#x0043f;&#x0043e;&#x00441;&#x00440;&#x00435;&#x00434;&#x00441;&#x00442;&#x00432;&#x00435;&#x0043d;&#x0043d;&#x0043e; &#x00438;&#x00437; &#x0043c;&#x00438;&#x0043d;&#x00438;&#x00441;&#x00442;&#x00435;&#x00440;&#x00441;&#x00442;&#x00432; &#x00437;&#x00434;&#x00440;&#x00430;&#x00432;&#x0043e;&#x0043e;&#x00445;&#x00440;&#x00430;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x0044f;. &#x00410;&#x00432;&#x00442;&#x0043e;&#x00440;&#x0044b; &#x00432;&#x0043a;&#x0043b;&#x0044e;&#x00447;&#x00438;&#x0043b;&#x00438; &#x00432; &#x0043e;&#x00431;&#x00437;&#x0043e;&#x00440; &#x00434;&#x00435;&#x00439;&#x00441;&#x00442;&#x00432;&#x00438;&#x0044f; &#x00432; &#x0043e;&#x00442;&#x0043d;&#x0043e;&#x00448;&#x00435;&#x0043d;&#x00438;&#x00438; &#x00443;&#x0043f;&#x0043e;&#x00442;&#x00440;&#x00435;&#x00431;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00442;&#x00430;&#x00431;&#x00430;&#x0043a;&#x00430; &#x00438; &#x00430;&#x0043b;&#x0043a;&#x0043e;&#x00433;&#x0043e;&#x0043b;&#x0044f;, &#x00431;&#x0043e;&#x00440;&#x0044c;&#x00431;&#x0044b; &#x00441; &#x0043d;&#x00435;&#x00434;&#x0043e;&#x00441;&#x00442;&#x00430;&#x00442;&#x0043e;&#x00447;&#x0043d;&#x0043e;&#x00439; &#x00444;&#x00438;&#x00437;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x0043e;&#x00439; &#x00430;&#x0043a;&#x00442;&#x00438;&#x00432;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x0044c;&#x0044e; &#x00438; &#x00432;&#x0044b;&#x00441;&#x0043e;&#x0043a;&#x00438;&#x0043c; &#x0043f;&#x0043e;&#x00442;&#x00440;&#x00435;&#x00431;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x00435;&#x0043c; &#x00441;&#x0043e;&#x0043b;&#x00438;, &#x00430; &#x00442;&#x00430;&#x0043a;&#x00436;&#x00435; &#x0043e;&#x00446;&#x00435;&#x0043d;&#x00438;&#x0043b;&#x00438; &#x00440;&#x00435;&#x00430;&#x0043a;&#x00446;&#x00438;&#x0044e; &#x00441;&#x00438;&#x00441;&#x00442;&#x00435;&#x0043c; &#x00437;&#x00434;&#x00440;&#x00430;&#x00432;&#x0043e;&#x0043e;&#x00445;&#x00440;&#x00430;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x0044f;, &#x00432;&#x0044b;&#x0044f;&#x00432;&#x00438;&#x0043b;&#x00438; &#x0043d;&#x00435;&#x00434;&#x0043e;&#x00441;&#x00442;&#x00430;&#x00442;&#x0043a;&#x00438; &#x00441;&#x00438;&#x00441;&#x00442;&#x00435;&#x0043c;&#x0044b; &#x00434;&#x00435;&#x00439;&#x00441;&#x00442;&#x00432;&#x00438;&#x00439; &#x00438; &#x0043f;&#x00440;&#x00435;&#x00434;&#x0043b;&#x0043e;&#x00436;&#x00438;&#x0043b;&#x00438; &#x00441;&#x0043f;&#x0043e;&#x00441;&#x0043e;&#x00431;&#x0044b; &#x00438;&#x00445; &#x00443;&#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x0044f;. &#x0041f;&#x0043e; &#x00441;&#x0043e;&#x00441;&#x00442;&#x0043e;&#x0044f;&#x0043d;&#x00438;&#x0044e; &#x0043d;&#x00430; 2018&#x000a0;&#x00433;&#x0043e;&#x00434; &#x00441;&#x00442;&#x00440;&#x00430;&#x0043d;&#x0044b; &#x00434;&#x00435;&#x0043c;&#x0043e;&#x0043d;&#x00441;&#x00442;&#x00440;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043b;&#x00438; &#x0043d;&#x00435;&#x00440;&#x00430;&#x00432;&#x0043d;&#x0043e;&#x0043c;&#x00435;&#x00440;&#x0043d;&#x0044b;&#x00439; &#x0043f;&#x00440;&#x0043e;&#x00433;&#x00440;&#x00435;&#x00441;&#x00441;. &#x0041e;&#x00441;&#x0043d;&#x0043e;&#x00432;&#x0043d;&#x0044b;&#x00435; &#x0043d;&#x00435;&#x00434;&#x0043e;&#x00441;&#x00442;&#x00430;&#x00442;&#x0043a;&#x00438; &#x0043f;&#x00440;&#x00435;&#x00434;&#x0043f;&#x00440;&#x00438;&#x0043d;&#x0044f;&#x00442;&#x0044b;&#x00445; &#x00434;&#x00435;&#x00439;&#x00441;&#x00442;&#x00432;&#x00438;&#x00439; &#x00431;&#x0044b;&#x0043b;&#x00438; &#x00441;&#x00432;&#x0044f;&#x00437;&#x00430;&#x0043d;&#x0044b; &#x00441; &#x0043d;&#x00435;&#x00434;&#x0043e;&#x00441;&#x00442;&#x00430;&#x00442;&#x0043e;&#x00447;&#x0043d;&#x0044b;&#x0043c; &#x00444;&#x00438;&#x0043d;&#x00430;&#x0043d;&#x00441;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00435;&#x0043c;, &#x0043e;&#x00433;&#x00440;&#x00430;&#x0043d;&#x00438;&#x00447;&#x00435;&#x0043d;&#x0043d;&#x0044b;&#x0043c;&#x00438; &#x00438;&#x0043d;&#x00441;&#x00442;&#x00438;&#x00442;&#x00443;&#x00446;&#x00438;&#x0043e;&#x0043d;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0044b;&#x0043c;&#x00438; &#x00432;&#x0043e;&#x00437;&#x0043c;&#x0043e;&#x00436;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x0044f;&#x0043c;&#x00438;&#x000a0;(&#x0043d;&#x00435;&#x00441;&#x0043c;&#x0043e;&#x00442;&#x00440;&#x0044f; &#x0043d;&#x00430; &#x0043d;&#x00430;&#x0043b;&#x00438;&#x00447;&#x00438;&#x00435; &#x00441;&#x0043f;&#x00435;&#x00446;&#x00438;&#x00430;&#x0043b;&#x0044c;&#x0043d;&#x0043e; &#x00441;&#x0043e;&#x00437;&#x00434;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043e;&#x00442;&#x00434;&#x00435;&#x0043b;&#x0043e;&#x00432; &#x0043f;&#x0043e; &#x00431;&#x0043e;&#x00440;&#x0044c;&#x00431;&#x00435; &#x00441; &#x0043d;&#x00435;&#x00438;&#x0043d;&#x00444;&#x00435;&#x0043a;&#x00446;&#x00438;&#x0043e;&#x0043d;&#x0043d;&#x0044b;&#x0043c;&#x00438; &#x00437;&#x00430;&#x00431;&#x0043e;&#x0043b;&#x00435;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f;&#x0043c;&#x00438;), &#x0043d;&#x00435;&#x00434;&#x0043e;&#x00441;&#x00442;&#x00430;&#x00442;&#x0043e;&#x00447;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x0044c;&#x0044e; &#x00434;&#x00435;&#x00439;&#x00441;&#x00442;&#x00432;&#x00438;&#x00439; &#x00432; &#x00440;&#x00430;&#x00437;&#x0043d;&#x0044b;&#x00445; &#x00441;&#x00435;&#x0043a;&#x00442;&#x0043e;&#x00440;&#x00430;&#x00445; &#x00432;&#x0043d;&#x00443;&#x00442;&#x00440;&#x00438; &#x00441;&#x00438;&#x00441;&#x00442;&#x00435;&#x0043c;&#x0044b; &#x00437;&#x00434;&#x00440;&#x00430;&#x00432;&#x0043e;&#x0043e;&#x00445;&#x00440;&#x00430;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00438; &#x00432;&#x0043d;&#x00435; &#x00435;&#x00435;, &#x00430; &#x00442;&#x00430;&#x0043a;&#x00436;&#x00435; &#x00441; &#x0043d;&#x00435;&#x00445;&#x00432;&#x00430;&#x00442;&#x0043a;&#x0043e;&#x00439; &#x00441;&#x00442;&#x00430;&#x0043d;&#x00434;&#x00430;&#x00440;&#x00442;&#x00438;&#x00437;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00445; &#x0043c;&#x00435;&#x00445;&#x00430;&#x0043d;&#x00438;&#x00437;&#x0043c;&#x0043e;&#x00432; &#x0043c;&#x0043e;&#x0043d;&#x00438;&#x00442;&#x0043e;&#x00440;&#x00438;&#x0043d;&#x00433;&#x00430; &#x00438; &#x0043e;&#x00446;&#x00435;&#x0043d;&#x0043a;&#x00438; &#x00434;&#x0043b;&#x0044f; &#x00438;&#x0043d;&#x00444;&#x0043e;&#x00440;&#x0043c;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f; &#x0043b;&#x00438;&#x00446;, &#x0043f;&#x00440;&#x00438;&#x0043d;&#x00438;&#x0043c;&#x00430;&#x0044e;&#x00449;&#x00438;&#x00445; &#x00441;&#x00442;&#x00440;&#x00430;&#x00442;&#x00435;&#x00433;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x00438;&#x00435; &#x00440;&#x00435;&#x00448;&#x00435;&#x0043d;&#x00438;&#x0044f;. &#x00414;&#x0043b;&#x0044f; &#x0043b;&#x00438;&#x0043a;&#x00432;&#x00438;&#x00434;&#x00430;&#x00446;&#x00438;&#x00438; &#x0043e;&#x00442;&#x00441;&#x00442;&#x00430;&#x00432;&#x00430;&#x0043d;&#x00438;&#x0044f; &#x0043f;&#x00440;&#x00430;&#x00432;&#x00438;&#x00442;&#x00435;&#x0043b;&#x0044c;&#x00441;&#x00442;&#x00432;&#x00430; &#x00434;&#x0043e;&#x0043b;&#x00436;&#x0043d;&#x0044b; &#x00431;&#x0043e;&#x0043b;&#x0044c;&#x00448;&#x00435; &#x00438;&#x0043d;&#x00432;&#x00435;&#x00441;&#x00442;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x00442;&#x0044c; &#x00432; &#x0044d;&#x00444;&#x00444;&#x00435;&#x0043a;&#x00442;&#x00438;&#x00432;&#x0043d;&#x0044b;&#x00435; &#x0043c;&#x00435;&#x00440;&#x0044b; &#x00431;&#x0043e;&#x00440;&#x0044c;&#x00431;&#x0044b;, &#x0043a;&#x0043e;&#x00442;&#x0043e;&#x00440;&#x0044b;&#x00435; &#x00440;&#x00435;&#x0043a;&#x0043e;&#x0043c;&#x00435;&#x0043d;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0044b; &#x00412;&#x0041e;&#x00417; &#x0043a;&#x00430;&#x0043a; &#x0043d;&#x00430;&#x00438;&#x00431;&#x0043e;&#x0043b;&#x00435;&#x00435; &#x0043f;&#x0043e;&#x0043f;&#x00443;&#x0043b;&#x0044f;&#x00440;&#x0043d;&#x0044b;&#x00435;, &#x00443;&#x0043b;&#x00443;&#x00447;&#x00448;&#x00430;&#x00442;&#x0044c; &#x00432;&#x00437;&#x00430;&#x00438;&#x0043c;&#x0043e;&#x00434;&#x00435;&#x00439;&#x00441;&#x00442;&#x00432;&#x00438;&#x00435; &#x00441;&#x00435;&#x0043a;&#x00442;&#x0043e;&#x00440;&#x0043e;&#x00432; &#x00438; &#x00440;&#x00430;&#x00441;&#x00448;&#x00438;&#x00440;&#x0044f;&#x00442;&#x0044c; &#x00432;&#x0043e;&#x00437;&#x0043c;&#x0043e;&#x00436;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438; &#x00438;&#x00441;&#x00441;&#x0043b;&#x00435;&#x00434;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x00438;&#x00439;, &#x0043c;&#x0043e;&#x0043d;&#x00438;&#x00442;&#x0043e;&#x00440;&#x00438;&#x0043d;&#x00433;&#x00430; &#x00438; &#x0043e;&#x00446;&#x00435;&#x0043d;&#x0043a;&#x00438;. &#x0041e;&#x0043f;&#x00438;&#x00440;&#x00430;&#x0044f;&#x00441;&#x0044c; &#x0043d;&#x00430; &#x0043e;&#x0043f;&#x0044b;&#x00442; &#x00420;&#x00430;&#x0043c;&#x0043e;&#x00447;&#x0043d;&#x0043e;&#x00439; &#x0043a;&#x0043e;&#x0043d;&#x00432;&#x00435;&#x0043d;&#x00446;&#x00438;&#x00438; &#x0043f;&#x0043e; &#x00431;&#x0043e;&#x00440;&#x0044c;&#x00431;&#x00435; &#x0043f;&#x00440;&#x0043e;&#x00442;&#x00438;&#x00432; &#x00442;&#x00430;&#x00431;&#x00430;&#x0043a;&#x00430;, &#x00412;&#x0041e;&#x00417; &#x00438; &#x00435;&#x00435; &#x0043c;&#x00435;&#x00436;&#x00434;&#x00443;&#x0043d;&#x00430;&#x00440;&#x0043e;&#x00434;&#x0043d;&#x0044b;&#x00435; &#x0043f;&#x00430;&#x00440;&#x00442;&#x0043d;&#x00435;&#x00440;&#x0044b; &#x00434;&#x0043e;&#x0043b;&#x00436;&#x0043d;&#x0044b; &#x00440;&#x00430;&#x00437;&#x00440;&#x00430;&#x00431;&#x0043e;&#x00442;&#x00430;&#x00442;&#x0044c; &#x00441;&#x00442;&#x00430;&#x0043d;&#x00434;&#x00430;&#x00440;&#x00442;&#x00438;&#x00437;&#x00438;&#x00440;&#x0043e;&#x00432;&#x00430;&#x0043d;&#x0043d;&#x0044b;&#x00439; &#x00432;&#x00441;&#x00435;&#x0043e;&#x00431;&#x0044a;&#x00435;&#x0043c;&#x0043b;&#x0044e;&#x00449;&#x00438;&#x00439; &#x0043c;&#x00435;&#x00442;&#x0043e;&#x00434; &#x0043c;&#x0043e;&#x0043d;&#x00438;&#x00442;&#x0043e;&#x00440;&#x00438;&#x0043d;&#x00433;&#x00430; &#x0043f;&#x0043e;&#x00442;&#x00440;&#x00435;&#x00431;&#x0043b;&#x00435;&#x0043d;&#x00438;&#x0044f; &#x00430;&#x0043b;&#x0043a;&#x0043e;&#x00433;&#x0043e;&#x0043b;&#x0044f;, &#x00441;&#x0043e;&#x0043b;&#x00438; &#x00438; &#x00432;&#x00440;&#x00435;&#x00434;&#x0043d;&#x0044b;&#x00445; &#x0043f;&#x00440;&#x0043e;&#x00434;&#x00443;&#x0043a;&#x00442;&#x0043e;&#x00432; &#x0043f;&#x00438;&#x00442;&#x00430;&#x0043d;&#x00438;&#x0044f;, &#x00430; &#x00442;&#x00430;&#x0043a;&#x00436;&#x00435; &#x0043e;&#x00446;&#x00435;&#x0043d;&#x0043a;&#x00438; &#x00444;&#x00438;&#x00437;&#x00438;&#x00447;&#x00435;&#x00441;&#x0043a;&#x0043e;&#x00439; &#x00430;&#x0043a;&#x00442;&#x00438;&#x00432;&#x0043d;&#x0043e;&#x00441;&#x00442;&#x00438; &#x00438; &#x00440;&#x00435;&#x00430;&#x0043a;&#x00446;&#x00438;&#x00438; &#x00441;&#x00438;&#x00441;&#x00442;&#x00435;&#x0043c;&#x0044b; &#x00437;&#x00434;&#x00440;&#x00430;&#x00432;&#x0043e;&#x0043e;&#x00445;&#x00440;&#x00430;&#x0043d;&#x00435;&#x0043d;&#x00438;&#x0044f;.</p></trans-abstract></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Noncommunicable diseases, such as cardiovascular diseases, cancers, chronic respiratory diseases and diabetes, claim a high proportion of overall mortality, pushing many people into poverty due to catastrophic spending on medical care.<xref rid="R1" ref-type="bibr"><sup>1</sup></xref> Yet noncommunicable diseases are mostly preventable. The United Nations (UN) General Assembly has adopted a series of resolutions<xref rid="R2" ref-type="bibr"><sup>2</sup></xref> which reflect the high-level commitment to prevention and control of noncommunicable diseases. In 2013, Member States of the World Health Organization (WHO) resolved to develop and implement national action plans, in line with the policy options proposed in the <italic>Global action plan for the prevention and control of noncommunicable diseases (2013&#x02013;2020)</italic>.<xref rid="R3" ref-type="bibr"><sup>3</sup></xref> Noncommunicable diseases are also embedded in sustainable development goal (SDG) target 3.4, that is, to reduce by one-third the premature mortality from noncommunicable diseases by 2030, and are linked to other SDGs, notably SDG&#x000a0;1 to end poverty.<xref rid="R4" ref-type="bibr"><sup>4</sup></xref> In 2017, the WHO Global Conference on Noncommunicable Diseases<xref rid="R5" ref-type="bibr"><sup>5</sup></xref> reaffirmed noncommunicable diseases as a sustainable development priority in the <italic>Montevideo roadmap 2018&#x02013;2030</italic>.<xref rid="R6" ref-type="bibr"><sup>6</sup></xref></p><p>The WHO estimates an economic return of 7 United States dollars (US$) per person for every dollar spent on so-called best buys &#x02013; evidence-based, highly cost&#x02013;effective policy interventions which tackle noncommunicable diseases.<xref rid="R7" ref-type="bibr"><sup>7</sup></xref> There could also be a reduction of 8.1 million premature deaths by 2030 if these best-buy options were fully implemented, which represents 15% of the total premature deaths due to noncommunicable diseases.<xref rid="R7" ref-type="bibr"><sup>7</sup></xref> Despite the rising burden of these diseases in low- and middle-income countries, only an estimated 1% of health funding in these countries is dedicated to prevention and clinical management.<xref rid="R7" ref-type="bibr"><sup>7</sup></xref> This level of spending is unlikely to have a significant impact.</p><p>Country-level gaps in legislative, regulatory, technical and financial capacities impede the translation of global commitments into national action. Most low- and middle-income countries have weak health systems, with limited domestic and international funding for prevention and health promotion interventions. Between 2000 and 2015, only 1.3% (US$&#x02009;5.2 billion) of total global development assistance for health was contributed to noncommunicable disease programmes.<xref rid="R8" ref-type="bibr"><sup>8</sup></xref> The problems are compounded by a lack of coordinated action across the relevant sectors within and outside governments.<xref rid="R9" ref-type="bibr"><sup>9</sup></xref><sup>&#x02013;</sup><xref rid="R11" ref-type="bibr"><sup>11</sup></xref> WHO has recommended that innovative sources of domestic financing be explored.<xref rid="R12" ref-type="bibr"><sup>12</sup></xref> Yet in most low- and middle-income countries, inadequate government funding and high out-of-pocket payments often prevent poorer people from accessing treatment for noncommunicable diseases.<xref rid="R8" ref-type="bibr"><sup>8</sup></xref><sup>,</sup><xref rid="R13" ref-type="bibr"><sup>13</sup></xref></p><p>We assessed the implementation status of best-buy interventions in seven Asian countries, which have participated in collaborative studies of noncommunicable diseases: Bhutan, Cambodia, Indonesia, Philippines, Sri Lanka, Thailand and Viet Nam. We also assessed gaps in institutional capacity and provided suggestions for improving policy implementation. All countries in this analysis are currently classified by the World Bank as lower-middle income, except Thailand, which is classified as upper-middle income.<xref rid="R14" ref-type="bibr"><sup>14</sup></xref> Population size ranges from under 1 million in Bhutan to more than 250 million in Indonesia. There are large variations in the prevalence of risk factors for noncommunicable disease, its associated burden and measures to tackle them across these seven countries (<xref rid="T1" ref-type="table">Table&#x000a0;1</xref>). </p><table-wrap id="T1" orientation="portrait" position="float"><label>Table 1</label><caption><title>Profile of seven Asian countries included in the analysis of best-buy interventions for the prevention and control of noncommunicable diseases in July 2018</title></caption><table frame="hsides" rules="groups"><col width="151" span="1"/><col width="68" span="1"/><col width="68" span="1"/><col width="70" span="1"/><col width="59" span="1"/><col width="62" span="1"/><col width="62" span="1"/><col width="62" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Variable</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Bhutan</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Cambodia</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Indonesia</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Philippines</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Sri Lanka</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Thailand</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Viet Nam</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Total population, millions in 2017</td><td valign="top" align="center" rowspan="1" colspan="1">0.8</td><td valign="top" align="center" rowspan="1" colspan="1">16</td><td valign="top" align="center" rowspan="1" colspan="1">258</td><td valign="top" align="center" rowspan="1" colspan="1">102</td><td valign="top" align="center" rowspan="1" colspan="1">21</td><td valign="top" align="center" rowspan="1" colspan="1">69</td><td valign="top" align="center" rowspan="1" colspan="1">94 (2016)</td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Economic and fiscal measures</bold><xref rid="R15" ref-type="bibr"><sup>15</sup></xref></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">GDP per capita in 2017, current US$</td><td valign="top" align="center" rowspan="1" colspan="1">3110</td><td valign="top" align="center" rowspan="1" colspan="1">1384</td><td valign="top" align="center" rowspan="1" colspan="1">3847</td><td valign="top" align="center" rowspan="1" colspan="1">2989</td><td valign="top" align="center" rowspan="1" colspan="1">4065</td><td valign="top" align="center" rowspan="1" colspan="1">6594</td><td valign="top" align="center" rowspan="1" colspan="1">2343</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Government revenue, excluding grants in 2016, % of GDP</td><td valign="top" align="center" rowspan="1" colspan="1">18.9</td><td valign="top" align="center" rowspan="1" colspan="1">17.4</td><td valign="top" align="center" rowspan="1" colspan="1">12.5</td><td valign="top" align="center" rowspan="1" colspan="1">15.2</td><td valign="top" align="center" rowspan="1" colspan="1">14.2</td><td valign="top" align="center" rowspan="1" colspan="1">20.0</td><td valign="top" align="center" rowspan="1" colspan="1">21.5 (2013)</td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Health expenditure</bold><xref rid="R15" ref-type="bibr"><sup>15</sup></xref></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Current health expenditure per capita in 2015, current US$</td><td valign="top" align="center" rowspan="1" colspan="1">91</td><td valign="top" align="center" rowspan="1" colspan="1">70</td><td valign="top" align="center" rowspan="1" colspan="1">112</td><td valign="top" align="center" rowspan="1" colspan="1">127</td><td valign="top" align="center" rowspan="1" colspan="1">118</td><td valign="top" align="center" rowspan="1" colspan="1">217</td><td valign="top" align="center" rowspan="1" colspan="1">117</td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Physical activity indicators</bold><xref rid="R16" ref-type="bibr"><sup>16</sup></xref></td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1">Prevalence of physical activity by adults age 18+ years in 2013, %</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Both sexes</td><td valign="top" align="center" rowspan="1" colspan="1">91</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td><td valign="top" align="center" rowspan="1" colspan="1">76</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td><td valign="top" align="center" rowspan="1" colspan="1">76</td><td valign="top" align="center" rowspan="1" colspan="1">70</td><td valign="top" align="center" rowspan="1" colspan="1">76</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Males</td><td valign="top" align="center" rowspan="1" colspan="1">94</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td><td valign="top" align="center" rowspan="1" colspan="1">75</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td><td valign="top" align="center" rowspan="1" colspan="1">83</td><td valign="top" align="center" rowspan="1" colspan="1">68</td><td valign="top" align="center" rowspan="1" colspan="1">78</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Females</td><td valign="top" align="center" rowspan="1" colspan="1">88</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td><td valign="top" align="center" rowspan="1" colspan="1">78</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td><td valign="top" align="center" rowspan="1" colspan="1">70</td><td valign="top" align="center" rowspan="1" colspan="1">72</td><td valign="top" align="center" rowspan="1" colspan="1">74</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Estimated deaths related to physical inactivity in 2013, %</td><td valign="top" align="center" rowspan="1" colspan="1">14.0</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td><td valign="top" align="center" rowspan="1" colspan="1">8.0</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td><td valign="top" align="center" rowspan="1" colspan="1">6.9</td><td valign="top" align="center" rowspan="1" colspan="1">5.1</td><td valign="top" align="center" rowspan="1" colspan="1">4.1</td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Alcohol indicators</bold><xref rid="R17" ref-type="bibr"><sup>17</sup></xref></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Total alcohol consumption per capita by alcohol drinkers older than 15 years in 2010, litres of pure alcohol</td><td valign="top" align="center" rowspan="1" colspan="1">6.9</td><td valign="top" align="center" rowspan="1" colspan="1">14.2</td><td valign="top" align="center" rowspan="1" colspan="1">7.1</td><td valign="top" align="center" rowspan="1" colspan="1">12.3</td><td valign="top" align="center" rowspan="1" colspan="1">20.1</td><td valign="top" align="center" rowspan="1" colspan="1">23.8</td><td valign="top" align="center" rowspan="1" colspan="1">17.2</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">National legal minimum age for on-premise sales of alcoholic beverages, years</td><td valign="top" align="center" rowspan="1" colspan="1">18</td><td valign="top" align="center" rowspan="1" colspan="1">None</td><td valign="top" align="center" rowspan="1" colspan="1">None</td><td valign="top" align="center" rowspan="1" colspan="1">18</td><td valign="top" align="center" rowspan="1" colspan="1">21</td><td valign="top" align="center" rowspan="1" colspan="1">20</td><td valign="top" align="center" rowspan="1" colspan="1">18</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">National maximum legal blood alcohol concentration, %</td><td valign="top" align="center" rowspan="1" colspan="1">0.08</td><td valign="top" align="center" rowspan="1" colspan="1">0.05</td><td valign="top" align="center" rowspan="1" colspan="1">Zero</td><td valign="top" align="center" rowspan="1" colspan="1">0.05</td><td valign="top" align="center" rowspan="1" colspan="1">0.08</td><td valign="top" align="center" rowspan="1" colspan="1">0.05</td><td valign="top" align="center" rowspan="1" colspan="1">Zero</td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1"><bold>Tobacco indicators</bold><xref rid="R18" ref-type="bibr"><sup>18</sup></xref></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">WHO FCTC, year of signatory; year of ratification</td><td valign="top" align="center" rowspan="1" colspan="1">2003; 2004</td><td valign="top" align="center" rowspan="1" colspan="1">2004; 2005</td><td valign="top" align="center" rowspan="1" colspan="1">Not signed or ratified</td><td valign="top" align="center" rowspan="1" colspan="1">2003; 2005</td><td valign="top" align="center" rowspan="1" colspan="1">2003; 2003</td><td valign="top" align="center" rowspan="1" colspan="1">2003; 2004</td><td valign="top" align="center" rowspan="1" colspan="1">2003; 2004</td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1">Prevalence of tobacco use among young people aged 13&#x02013;15 years in 2016, %</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Both sexes</td><td valign="top" align="center" rowspan="1" colspan="1">30.2</td><td valign="top" align="center" rowspan="1" colspan="1">2.4</td><td valign="top" align="center" rowspan="1" colspan="1">12.7</td><td valign="top" align="center" rowspan="1" colspan="1">12.0</td><td valign="top" align="center" rowspan="1" colspan="1">3.7</td><td valign="top" align="center" rowspan="1" colspan="1">15.0</td><td valign="top" align="center" rowspan="1" colspan="1">4.0</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Males</td><td valign="top" align="center" rowspan="1" colspan="1">39.0</td><td valign="top" align="center" rowspan="1" colspan="1">2.9</td><td valign="top" align="center" rowspan="1" colspan="1">23.0</td><td valign="top" align="center" rowspan="1" colspan="1">17.6</td><td valign="top" align="center" rowspan="1" colspan="1">6.7</td><td valign="top" align="center" rowspan="1" colspan="1">21.8</td><td valign="top" align="center" rowspan="1" colspan="1">6.9</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Females</td><td valign="top" align="center" rowspan="1" colspan="1">23.2</td><td valign="top" align="center" rowspan="1" colspan="1">1.9</td><td valign="top" align="center" rowspan="1" colspan="1">2.4</td><td valign="top" align="center" rowspan="1" colspan="1">7.0</td><td valign="top" align="center" rowspan="1" colspan="1">0.7</td><td valign="top" align="center" rowspan="1" colspan="1">8.1</td><td valign="top" align="center" rowspan="1" colspan="1">1.3</td></tr><tr><td colspan="8" valign="top" align="left" scope="col" rowspan="1">Prevalence of tobacco smoking among individuals older than 15 years in 2016, %</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Both sexes</td><td valign="top" align="center" rowspan="1" colspan="1">7.4</td><td valign="top" align="center" rowspan="1" colspan="1">21.8</td><td valign="top" align="center" rowspan="1" colspan="1">NA</td><td valign="top" align="center" rowspan="1" colspan="1">22.7</td><td valign="top" align="center" rowspan="1" colspan="1">15.0</td><td valign="top" align="center" rowspan="1" colspan="1">20.7</td><td valign="top" align="center" rowspan="1" colspan="1">22.5</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Males</td><td valign="top" align="center" rowspan="1" colspan="1">10.8</td><td valign="top" align="center" rowspan="1" colspan="1">33.6</td><td valign="top" align="center" rowspan="1" colspan="1">64.9</td><td valign="top" align="center" rowspan="1" colspan="1">40.3</td><td valign="top" align="center" rowspan="1" colspan="1">29.4</td><td valign="top" align="center" rowspan="1" colspan="1">40.5</td><td valign="top" align="center" rowspan="1" colspan="1">45.3</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">&#x000a0;&#x000a0;&#x000a0;&#x000a0;Females</td><td valign="top" align="center" rowspan="1" colspan="1">3.1</td><td valign="top" align="center" rowspan="1" colspan="1">11.0</td><td valign="top" align="center" rowspan="1" colspan="1">2.1</td><td valign="top" align="center" rowspan="1" colspan="1">5.1</td><td valign="top" align="center" rowspan="1" colspan="1">0.1</td><td valign="top" align="center" rowspan="1" colspan="1">2.2</td><td valign="top" align="center" rowspan="1" colspan="1">1.1</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Total tobacco taxes, % of retail price</td><td valign="top" align="center" rowspan="1" colspan="1">Tobacco banned</td><td valign="top" align="center" rowspan="1" colspan="1">25.2</td><td valign="top" align="center" rowspan="1" colspan="1">57.4</td><td valign="top" align="center" rowspan="1" colspan="1">62.6</td><td valign="top" align="center" rowspan="1" colspan="1">62.1</td><td valign="top" align="center" rowspan="1" colspan="1">73.5</td><td valign="top" align="center" rowspan="1" colspan="1">35.7</td></tr></tbody></table><table-wrap-foot><p>FCTC: Framework Convention on Tobacco Control; GDP: gross domestic product; NA: data unavailable; US$: United States dollar.</p></table-wrap-foot></table-wrap><p>Although these seven countries have a similar pace of socioeconomic development, they are diverse in terms of population size, health-system structure and decentralization of governance for health (fully devolved to local governments in Indonesia and the Philippines, and partially devolved in Sri Lanka). Lessons from their experiences can be shared with other countries striving to implement their national action plans on noncommunicable diseases.</p></sec><sec><title>Approach</title><p>We based our analysis on the policy options in the six objectives in the global action plan on noncommunicable dieases.<xref rid="R3" ref-type="bibr"><sup>3</sup></xref> These objectives form the guiding framework for WHO Member States to develop their national action plans (<xref ref-type="fig" rid="F1">Fig.&#x000a0;1</xref>). National research capacities (objective 5) and monitoring and evaluation (objective 6) provide evidence which supports the application of best-buy interventions (objective 3) and monitors progress towards achieving targets. Health-systems strengthening (objective 4) supports the implementation of the action plan. All four objectives (3, 4, 5 and 6) should be enhanced by good governance (objective 2) and a heightened noncommunicable diseases priority that sustains the agenda across successive governments (objective 1).</p><fig id="F1" fig-type="figure" orientation="portrait" position="float"><label>Fig. 1</label><caption><p>Noncommunicable diseases global action plan framework: the interlinks between six objectives in achieving national targets on noncommunicable diseases </p></caption><graphic xlink:href="BLT.18.220483-F1"/><attrib>Note: Based on the <italic>WHO Global action plan for the prevention and control of noncommunicable diseases 2013&#x02013;2020</italic>.<xref rid="R3" ref-type="bibr"><sup>3</sup></xref></attrib></fig><p>Given the six objectives act in synergy to contribute to noncommunicable diseases prevention and control, we did not attempt to address all of them, but to focus on implementation of the best buys for four major noncommunicable diseases risk factors (tobacco, alcohol, unhealthy diet and physical activity) and for health-systems response.</p><p>In the first half of 2018, we gathered information from country profiles in a range of sources from the published literature: (i)&#x000a0;the <italic>WHO report on the global tobacco epidemic 2017</italic> which was compiled by the Framework Convention on Tobacco Control (FCTC) secretariat;<xref rid="R18" ref-type="bibr"><sup>18</sup></xref> (ii)&#x000a0;the WHO <italic>Global status report on alcohol and health 2018</italic>;<xref rid="R19" ref-type="bibr"><sup>19</sup></xref> (iii)&#x000a0;the <italic>WHO Global status report on noncommunicable diseases 2010</italic>;<xref rid="R20" ref-type="bibr"><sup>20</sup></xref> (iv)&#x000a0;the <italic>Noncommunicable diseases progress monitor 2017</italic>;<xref rid="R21" ref-type="bibr"><sup>21</sup></xref> (v)&#x000a0;national capacity survey data on physical activity, salt policy and health-systems response to developing treatment guidelines from the WHO <italic>Global Health Observatory data repository</italic>;<xref rid="R22" ref-type="bibr"><sup>22</sup></xref> and (vi)&#x000a0;the <italic>Noncommunicable diseases country profiles 2018</italic> report on availability of essential medicines for noncommunicable diseases.<xref rid="R23" ref-type="bibr"><sup>23</sup></xref> Additional published literature was retrieved from a search of PubMed&#x000ae; and Scopus online databases. We used personal contacts with the health ministries in each respective country to obtain further information on the institutional capacity to address noncommunicable diseases.</p></sec><sec><title>Implementation of best buys</title><p><xref rid="T2" ref-type="table">Table&#x000a0;2</xref> provides a summary of the implementation status of best-buy interventions across the seven countries.</p><table-wrap id="T2" orientation="portrait" position="float"><label>Table 2</label><caption><title>Implementation status of best-buy interventions for the prevention and control of noncommunicable diseases in seven Asian countries in July 2018</title></caption><table frame="hsides" rules="groups"><col width="90" span="1"/><col width="84" span="1"/><col width="77" span="1"/><col width="78" span="1"/><col width="76" span="1"/><col width="77" span="1"/><col width="72" span="1"/><col width="92" span="1"/><col width="77" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Best-buy intervention</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Indicator description</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Bhutan</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Cambodia</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Indonesia</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Philippines</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Sri Lanka</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Thailand</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Viet Nam</th></tr></thead><tbody><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Tobacco demand-reduction measures</bold><xref rid="R18" ref-type="bibr"><sup>18</sup></xref></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1. Increase excise taxes and prices on tobacco products </td><td valign="top" align="left" rowspan="1" colspan="1">Total taxes as % of the price of the most sold brand of cigarettes was maximum 75% and above, minimum 51%<xref rid="R24" ref-type="bibr"><sup>24</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Not applicable, as sale of tobacco banned in Bhutan</td><td valign="top" align="left" rowspan="1" colspan="1">Total tax: 25.2% of retail price in 2016. Retail cigarette price affordable. No changes between 2008 and 2016</td><td valign="top" align="left" rowspan="1" colspan="1">Total tax: 57.4% of retail price in 2016. Retail cigarette price affordable. Cigarettes more affordable in 2016 than 2008</td><td valign="top" align="left" rowspan="1" colspan="1">Total tax: 62.6% of retail cigarette price in 2016. Cigarettes less affordable in 2016 than 2008</td><td valign="top" align="left" rowspan="1" colspan="1">Total tax: 62.1% of retail cigarette price in 2016. Tobacco price affordable. No changes between 2008 and 2016</td><td valign="top" align="left" rowspan="1" colspan="1">Total tax: 73.5% of retail price in 2016. Retail cigarette price affordable. No changes between 2008 and 2016</td><td valign="top" align="left" rowspan="1" colspan="1">Total tax: 35.7% of retail cigarette price in 2016. Cigarettes more affordable in 2016 than in 2008</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">2. Eliminate exposure to second-hand tobacco smoke in all indoor workplaces, public places and public transport</td><td valign="top" align="left" rowspan="1" colspan="1">Compliance score for smoke-free environments as per WHO report.<xref rid="R18" ref-type="bibr"><sup>18</sup></xref> High compliance:&#x02009;8&#x02013;10; moderate compliance:&#x02009;3&#x02013;7; minimal compliance:&#x02009;0&#x02013;2</td><td valign="top" align="left" rowspan="1" colspan="1">Compliance score: 10/10 in 2016. Not yet enforced compliance in caf&#x000e9;s, pubs, bars, government facilities and universities</td><td valign="top" align="left" rowspan="1" colspan="1">Compliance score: 5/10 in 2016. Not yet enforced compliance in restaurant and government facilities</td><td valign="top" align="left" rowspan="1" colspan="1">Compliance score: 1/10 in 2016. Not yet introduced smoke-free regulation in government facilities, indoor offices, restaurant, caf&#x000e9;s, pubs and bars</td><td valign="top" align="left" rowspan="1" colspan="1">Compliance score: 5/10 in 2016. Not yet introduced smoke-free regulation in indoor offices, restaurants, caf&#x000e9;s, pubs and bars</td><td valign="top" align="left" rowspan="1" colspan="1">Compliance score: 6/10 in 2016. Not yet introduced smoke-free regulation in restaurants, caf&#x000e9;s, pubs and bars</td><td valign="top" align="left" rowspan="1" colspan="1">Compliance score: 7/10 (score from 2013 MPOWER report<xref rid="R25" ref-type="bibr"><sup>25</sup></xref>). Complete compliance with smoke-free regulation in health-care facilities, educational facilities, universities, government facilities, indoor offices, restaurants, caf&#x000e9;s, pubs and bars and public transport</td><td valign="top" align="left" rowspan="1" colspan="1">Compliance score: 5/10 in 2016. Not yet introduced smoke-free regulation in caf&#x000e9;, pubs, bars and public transport</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">3. Implement plain or standardized packaging and/or large graphic health warnings on all tobacco packages</td><td valign="top" align="left" rowspan="1" colspan="1">Mandates plain or standardized packaging or large graphic warnings with all appropriate characteristics</td><td valign="top" align="left" rowspan="1" colspan="1">Not applicable</td><td valign="top" align="left" rowspan="1" colspan="1">Mandates pictorial and text health warnings on packaging of cigarettes, other smoked tobacco and smokeless tobacco, covering 55% of front and back areas. Two specific health warning approved</td><td valign="top" align="left" rowspan="1" colspan="1">Mandates pictorial and text health warnings on packaging of cigarettes, other smoked tobacco and smokeless tobacco, covering 40% of front and back areas. Five specific health warnings approved</td><td valign="top" align="left" rowspan="1" colspan="1">Mandates pictorial and text health warnings on packaging of cigarettes, other smoked tobacco and smokeless tobacco, covering 50% of front and back areas. Twelve specific health warnings approved</td><td valign="top" align="left" rowspan="1" colspan="1">Mandates text and pictorial health warnings on packaging of cigarettes and other smoked tobacco, covering 80% of front and back areas. (Ban on smokeless tobacco.) Four specific health warnings approved</td><td valign="top" align="left" rowspan="1" colspan="1">Mandates text and pictorial health warnings on packaging of cigarettes and other smoke tobacco, covering 85% of front and back areas. Ban on smokeless tobacco. Ten specific health warnings approved</td><td valign="top" align="left" rowspan="1" colspan="1">Mandates text and pictorial health warnings on packaging of cigarettes, other smoked tobacco and smokeless tobacco, covering 50% of front and back areas. Six specific health warnings approved</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">4. Enact and enforce comprehensive bans on tobacco advertising, promotion and sponsorship</td><td valign="top" align="left" rowspan="1" colspan="1">Compliance score as per WHO report.<xref rid="R18" ref-type="bibr"><sup>18</sup></xref><break/>High compliance: 8&#x02013;10; moderate compliance:&#x02009;3&#x02013;7; minimal compliance:&#x02009;0&#x02013;2</td><td valign="top" align="left" rowspan="1" colspan="1">Compliance score on direct advertising ban: 10/10; promotions and sponsorship ban: 10/10; indirect promotions ban: 10/10</td><td valign="top" align="left" rowspan="1" colspan="1">Compliance score on direct advertising ban: 8/10. No ban on indirect promotions except on publicizing corporate social responsibility activities of tobacco companies</td><td valign="top" align="left" rowspan="1" colspan="1">No ban on direct tobacco advertising in TV or radio, magazines, billboards, point-of-sales or the internet. Compliance score on free distribution ban: 3/10; promotional discounts on television ban: 0/10; non-tobacco products identified with tobacco brand names ban: 1/10</td><td valign="top" align="left" rowspan="1" colspan="1">Compliance score on direct advertising ban: 6/10. No ban on promotions except appearance of tobacco brands on television or films (product placement) score: 9/10; indirect promotions ban: 6/10</td><td valign="top" align="left" rowspan="1" colspan="1">Compliance score on direct advertising ban: 8/10; promotions ban: 5&#x02013;10/10; indirect promotions ban: 6/10</td><td valign="top" align="left" rowspan="1" colspan="1">Comprehensive regulations on advertising, market promotion and sponsorship, and indirect promotions (no score reported in 2017 WHO MPOWER report<xref rid="R25" ref-type="bibr"><sup>25</sup></xref>)</td><td valign="top" align="left" rowspan="1" colspan="1">Compliance score on direct advertising ban: 10/10; promotions ban: 6&#x02013;8/10; indirect promotions ban: 6/10</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">5. Implement effective mass-media campaigns that educate the public about the harms of smoking/tobacco use and second-hand smoke</td><td valign="top" align="left" rowspan="1" colspan="1">Implemented a national anti-tobacco mass-media campaign designed to support tobacco control, of at least 3 weeks duration with all appropriate characteristics<xref rid="R24" ref-type="bibr"><sup>24</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">No national media campaign implemented between 2014 and 2016</td><td valign="top" align="left" rowspan="1" colspan="1">National media campaign implemented on television and radio between 2014 and 2016. Content and target audience guided by research, though no post-campaign evaluation was made</td><td valign="top" align="left" rowspan="1" colspan="1">Media campaign implemented between 2014 and 2016. Content and target audience guided by research, with post-campaign evaluation</td><td valign="top" align="left" rowspan="1" colspan="1">Comprehensive media campaign implemented between 2014 and 2016. Content and target audience guided by research, with post-campaign evaluation</td><td valign="top" align="left" rowspan="1" colspan="1">No media campaign implemented between 2014 and 2016</td><td valign="top" align="left" rowspan="1" colspan="1">Comprehensive media campaign implemented between 2014 and 2016. Content and target audience guided by research, with post-campaign evaluation</td><td valign="top" align="left" rowspan="1" colspan="1">Comprehensive media campaign implemented between 2014 and 2016. Content and target audience guided by research, with post-campaign evaluation</td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Harmful use of alcohol reduction measures</bold><xref rid="R19" ref-type="bibr"><sup>19</sup></xref></td></tr><tr><td rowspan="2" valign="top" align="left" scope="row" colspan="1">1. Enact and enforce restrictions on the physical availability of retailed alcohol (via reduced hours of sale)</td><td valign="top" align="left" rowspan="1" colspan="1">National legal minimum age for on- and off-premise sales of alcoholic beverages<xref rid="R19" ref-type="bibr"><sup>19</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">18 years</td><td valign="top" align="left" rowspan="1" colspan="1">No defined legal age</td><td valign="top" align="left" rowspan="1" colspan="1">21 years </td><td valign="top" align="left" rowspan="1" colspan="1">18 years</td><td valign="top" align="left" rowspan="1" colspan="1">21 years</td><td valign="top" align="left" rowspan="1" colspan="1">20 years</td><td valign="top" align="left" rowspan="1" colspan="1">18 years </td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Restrictions for on- and off-premise sales of alcoholic beverages by hours, days, places of sale, density of outlets, for specific events, to intoxicated persons, at petrol stations<xref rid="R19" ref-type="bibr"><sup>19</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Restrictions for all categories except density</td><td valign="top" align="left" rowspan="1" colspan="1">No restrictions</td><td valign="top" align="left" rowspan="1" colspan="1">Restrictions only for hours and places</td><td valign="top" align="left" rowspan="1" colspan="1">Restrictions only for hours, places, density and specific events</td><td valign="top" align="left" rowspan="1" colspan="1">Restrictions for all categories</td><td valign="top" align="left" rowspan="1" colspan="1">Restrictions for all categories except density and specific events</td><td valign="top" align="left" rowspan="1" colspan="1">Restrictions only by place, density and for intoxicated persons</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">2. Enact and enforce bans or comprehensive restrictions on exposure to alcohol advertising (across multiple types of media)</td><td valign="top" align="left" rowspan="1" colspan="1">Legally binding regulations on alcohol advertising, product placement, sponsorship, sales promotion, health warning labels on advertisements and containers</td><td valign="top" align="left" rowspan="1" colspan="1">Yes, except advertising on containers</td><td valign="top" align="left" rowspan="1" colspan="1">Regulations only on alcohol sponsorship</td><td valign="top" align="left" rowspan="1" colspan="1">Yes, except advertising on containers</td><td valign="top" align="left" rowspan="1" colspan="1">Regulations only for health warning labels on alcohol advertisements and containers</td><td valign="top" align="left" rowspan="1" colspan="1">Yes, except advertising on containers</td><td valign="top" align="left" rowspan="1" colspan="1">Yes, except advertising on containers</td><td valign="top" align="left" rowspan="1" colspan="1">Yes, except advertising on containers</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">3.Increase excise taxes on alcoholic beverages</td><td valign="top" align="left" rowspan="1" colspan="1">Excise tax on beer, wine and spirits</td><td valign="top" align="left" rowspan="1" colspan="1">Yes, except for spirits</td><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">Yes</td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Unhealthy diet reduction measures</bold><xref rid="R22" ref-type="bibr"><sup>22</sup></xref></td></tr><tr><td rowspan="2" valign="top" align="left" scope="row" colspan="1">1. Adopt national policies to reduce population salt/sodium consumption</td><td valign="top" align="left" rowspan="1" colspan="1">Adopted national salt policies</td><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">No</td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Applies voluntary or mandatory salt cut-offs on selected foods</td><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="left" rowspan="1" colspan="1">Applies voluntary salt reduction in processed food and snacks with healthier choice logo. Mandatory regulation for food labelling in guideline daily amounts</td><td valign="top" align="left" rowspan="1" colspan="1">No</td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Physical activity</bold><xref rid="R22" ref-type="bibr"><sup>22</sup></xref></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1. Implement communitywide public education and awareness campaign for physical activity, which includes a mass media campaign</td><td valign="top" align="left" rowspan="1" colspan="1">Country has implemented, within past 5&#x000a0;years, at least one recent national public awareness programme on physical activity</td><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">No</td><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">No</td></tr><tr><td colspan="9" valign="top" align="left" scope="col" rowspan="1"><bold>Health systems</bold><xref rid="R24" ref-type="bibr"><sup>24</sup></xref></td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">1. Member State has national management guidelines for four major noncommunicable diseases through a primary care approach</td><td valign="top" align="left" rowspan="1" colspan="1">Availability of national guidelines for the management of cardiovascular diseases, diabetes, cancer and chronic respiratory diseases</td><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">Yes</td><td valign="top" align="left" rowspan="1" colspan="1">Yes</td></tr><tr><td rowspan="2" valign="top" align="left" scope="row" colspan="1">2. Drug therapy for diabetes mellitus and hypertension using total risk approach), and counselling to individuals who have had a heart attack or stroke and to persons with high risk (&#x02265;&#x02009;30%, or &#x02265;&#x02009;20%) of a fatal and non-fatal cardiovascular event in the next 10 years</td><td valign="top" align="left" rowspan="1" colspan="1">Proportion of primary health-care facilities offering cardiovascular risk stratification for the management of patients at high risk for heart attack and stroke<xref rid="R23" ref-type="bibr"><sup>23</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">Less than 25%</td><td valign="top" align="left" rowspan="1" colspan="1">Less than 25% </td><td valign="top" align="left" rowspan="1" colspan="1">Less than 25% </td><td valign="top" align="left" rowspan="1" colspan="1">More than 50% </td><td valign="top" align="left" rowspan="1" colspan="1">More than 50% </td><td valign="top" align="left" rowspan="1" colspan="1">More than 50% </td><td valign="top" align="left" rowspan="1" colspan="1">Less than 25% </td></tr><tr><td valign="top" colspan="1" align="left" scope="row" rowspan="1">Availability of selected noncommunicable diseases medicines at 50% or more of primary-health care facilities<xref rid="R22" ref-type="bibr"><sup>22</sup></xref></td><td valign="top" align="left" rowspan="1" colspan="1">4/12 drugs </td><td valign="top" align="left" rowspan="1" colspan="1">3/12 drugs </td><td valign="top" align="left" rowspan="1" colspan="1">11/12 drugs </td><td valign="top" align="left" rowspan="1" colspan="1">4/12 drugs </td><td valign="top" align="left" rowspan="1" colspan="1">11/12 drugs </td><td valign="top" align="left" rowspan="1" colspan="1">9/12 drugs </td><td valign="top" align="left" rowspan="1" colspan="1">2/12 drugs</td></tr></tbody></table><table-wrap-foot><p>WHO: World Health Organization.</p><p>Note: Affordability of cigarettes is defined by the percentage of per capita gross domestic product required to purchase 2000 cigarettes of the most sold brand.<xref rid="R18" ref-type="bibr"><sup>18</sup></xref></p></table-wrap-foot></table-wrap><sec><title>Tobacco control</title><p>All six countries that are State Parties to the WHO FCTC,<xref rid="R18" ref-type="bibr"><sup>18</sup></xref> and also Indonesia, which is not a State Party to the Convention, have implemented tobacco control interventions. There are five indicators to monitor progress as mandated by the Convention. </p><p>First, countries are required to increase excise taxes and prices on tobacco products to achieve the total tax rate between 51% and 75% of retail price of the most sold brand of cigarettes. By 2016, no country in our analysis had achieved the target of 75%. Thailand had the highest tax rate of 73.5%, while Cambodia had the lowest rate of 25.2%. Cigarettes were more affordable (defined according to the cost of cigarettes relative to per capita income) in 2016 than in 2008 in two countries, Indonesia and Viet Nam, but less affordable in 2016 than in 2008 in the Philippines.</p><p>Second, countries are required to eliminate exposure to second-hand tobacco smoke in all indoor workplaces, public places and transport. Bhutan (which has a total ban on tobacco) had the highest compliance rate (score: 10 out of a maximum 10), followed by Thailand (score: 7/10), while Indonesia (score: 1/10) had yet to scale-up compliance to protect the health of non-smokers.</p><p>Third, countries are required to introduce plain or standardized packaging or large graphic health warnings on all tobacco packages. Thailand and Sri Lanka were the two best-performing countries, as text and pictorial health warnings covered 85% and 80% of the front and back areas of cigarettes package, respectively. Health warnings covered only 40% of package areas in Indonesia.</p><p>Fourth, countries are required to enact and enforce comprehensive bans on tobacco advertising, promotion and sponsorship. Bhutan had the highest level of compliance with a score of 10 out of 10 each for direct and indirect bans, followed by Viet Nam with a compliance score of 10/10 for a direct ban and 6/10 for an indirect ban. Indonesia had the lowest score (1/10) on eliminating exposure to second-hand tobacco smoke; the country had no bans on direct advertising or sponsorship; and low compliance (score 3/10) on banning free tobacco distribution, </p><p>Fifth, countries are required to implement effective mass-media campaigns to educate the public about the harms of smoking and second-hand smoke. All countries except Bhutan and Sri Lanka had comprehensive campaigns in the media in 2014 and 2016.</p></sec><sec><title>Alcohol control</title><p>There are three indicators in the <italic>Global status report on alcohol and health 2018</italic>, that were used to monitor progress on reduction of harmful use of alcohol.<xref rid="R19" ref-type="bibr"><sup>19</sup></xref></p><p>First, countries need to enact and enforce restrictions on the physical availability of retailed alcohol. The legal minimum age for on- and off-premise sales of alcoholic beverages in 2018 was the highest in Indonesia and Sri Lanka (21&#x000a0;years), followed by Bhutan, Philippines and Viet Nam (18&#x000a0;years), while Cambodia did not have a defined legal age. All countries in this study except Cambodia had introduced restrictions on the on- and off-premise sales of alcoholic beverages by timing or place, although these was not yet comprehensive.<xref rid="R19" ref-type="bibr"><sup>19</sup></xref></p><p>Second, countries need to enact and enforce bans or comprehensive restrictions on exposure to alcohol advertising in all types of media, product placement, sponsorship and sales promotion, and implement health warning labels on alcohol advertisements and containers. We found that almost all countries had introduced regulations on advertising for all categories of media except on alcohol drinks containers.</p><p>Third, countries need to increase excise taxes on alcoholic beverages including beer, wine and spirits. The <italic>Global status report on alcohol and health 2018</italic><xref rid="R19" ref-type="bibr"><sup>19</sup></xref> does not provide detailed information, such as tax rates, trends of tax rates and changes of affordability of alcoholic beverages. However, most countries had imposed excise taxes for all alcoholic beverages, except on spirits in Bhutan. The available information would not be helpful for monitoring progress on changes of affordability and specific policy interventions.</p></sec><sec><title>Unhealthy diet</title><p>The availability of a salt policy is currently the only indicator used by WHO to monitor progress on unhealthy diet.<xref rid="R21" ref-type="bibr"><sup>21</sup></xref> Salt policies cover four best buys interventions; (i)&#x000a0;reformulating and setting target of salt in foods, (ii)&#x000a0;promoting an enabling environment for lower sodium options, (iii)&#x000a0;promoting behaviour change through media campaign, (iv)&#x000a0;implementing front-of-pack labelling. Thailand had introduced a salt and sodium reduction policy for 2016&#x02013;2025, focusing on labelling, legislation and product reformulation.<sup>24</sup> In 2016, Thailand adopted national policies to reduce population salt and sodium consumption, in the form of a voluntary salt reduction in processed food and snacks. Manufacturers who comply with the salt reduction recommendation (including those on fat and sugar) receive a healthier choice logo by the food and drug administration of the health ministry. A regulation was introduced in 2016 in Thailand, for mandatory package labelling (of salt, fat, sugar, energy and other contents) through the guideline daily amount. Bhutan and Sri Lanka have drafted salt reduction strategies, although an explicit policy on salt reduction was not yet available. Average daily salt intake was 10.8&#x000a0;g (in 2010) and 8.0&#x000a0;g (in 2012) in Thailand and Sri Lanka, respectively,<xref rid="R26" ref-type="bibr"><sup>26</sup></xref> which is more than the 5&#x000a0;g recommended by the WHO.<xref rid="R27" ref-type="bibr"><sup>27</sup></xref> Population behaviour change actions, such as creating awareness on high salt intake and empowering people to change their behaviours, had been introduced in Bhutan and Sri Lanka.</p></sec><sec><title>Physical activity</title><p>Implementing public education and awareness campaigns is the indicator for monitoring progress of promoting physical activity.<xref rid="R21" ref-type="bibr"><sup>21</sup></xref> By 2016, Cambodia and Viet Nam had not implemented any programme activities that support behavioural change in the previous 5&#x000a0;years. The <italic>Global action plan on physical activity (2018&#x02013;2030)</italic>, adopted by World Health Assembly resolution WHA71.6<xref rid="R28" ref-type="bibr"><sup>28</sup></xref> in May 2018, urged the WHO Member States to implement the promotion of physical activity and requested the WHO to develop global monitoring and reporting systems.</p></sec><sec><title>Health-systems response</title><p>Two indicators are proposed for monitoring health-systems response to noncommunicable diseases: availability of treatment guidelines and availability of essential medicines at primary level facilities.<xref rid="R21" ref-type="bibr"><sup>21</sup></xref> Access to essential medicines supports reduction of premature mortality in SDG target 3.4.</p><p>By 2016, all seven countries had developed evidence-based national guidelines for the management of four major conditions through a primary health-care approach, although there was no detail on the scope and contents of guidelines. Three countries, Philippines, Sri Lanka and Thailand, reported that more than 50% of their primary health-care facilities offered cardiovascular risk management of patients at risk of heart attack and stroke. The remaining four countries reported fewer than 25% of their primary care facilities offered these services.</p><p>Indonesia and Sri Lanka reported that 11 out of 12 priority noncommunicable diseases medicines were available in more than 50% of their primary care facilities. Viet Nam and Cambodia needed to scale-up availability of these medicines, as only 2/12 and 3/12 medicines for noncommunicable diseases were available, respectively.</p><p>In addition to the cross-country analysis in <xref rid="T2" ref-type="table">Table&#x000a0;2</xref>, <xref ref-type="boxed-text" rid="B1">Box&#x000a0;1</xref> provides a synthesis of intra-country analysis of their noncommunicable diseases interventions, achievements and gaps.</p><boxed-text id="B1" position="float" orientation="portrait"><label>Box&#x000a0;1</label><caption><title>Best-buy interventions for the prevention and control of noncommunicable diseases: summary of achievements and gaps in seven Asian countries in July 2018</title></caption><sec><title>Bhutan</title><p>Although smoking is illegal in Bhutan, the current prevalence of tobacco use among young people and adults is estimated to be 30.2% and 7.4%, respectively in 2016. The country has good performance in ensuring smoke-free public spaces (compliance score 10/10) and total bans on tobacco advertising, promotion and sponsorship. Although excise taxes and restrictions on the availability and advertising of alcohol are in place, the legal minimum age for sales of alcohol beverage (18 years old) is the lowest among the seven countries. Bhutan is developing strategies on reduction of daily salt consumption and promotion of physical activity. While clinical guidelines for the management of four major noncommunicable diseases are produced, only four out of 12 essential medicines for management of these diseases are available in more than 50% of primary care facilities.</p></sec><sec><title>Cambodia</title><p>Tobacco control policies need considerable improvement. The tobacco tax rate is the lowest among the seven countries, 25.2% of the retail price. No price changes between 2008 and 2016 means that cigarettes are affordable by the WHO definition.<xref rid="R18" ref-type="bibr"><sup>18</sup></xref> There is room to strengthen compliance on smoke-free public spaces, increase the health warning areas on cigarette packages (55%) and introduce a ban on indirect marketing promotions. Cambodia needs to introduce a legal minimum age for sale of alcoholic beverages and to restrict alcohol availability, limit daily salt consumption and promote physical activity. The country needs to scale-up the availability of essential medicines in primary care facilities.</p></sec><sec><title>Indonesia</title><p>A very high prevalence of tobacco use was reported in Indonesia; 12.7% of young people and 64.9% of men are current tobacco users. Though not a State Party to the WHO Framework Convention on Tobacco Control, the government needs to increase the low tobacco tax rate (57.4%) and make cigarettes less affordable to discourage new smokers, scale-up the current low level (score 1/10) of compliance on smoke-free public spaces, increase health warning areas on cigarette packages (currently 40% of front and back areas), and introduce a ban on advertising and market promotion. Alcohol consumption is religiously prohibited and legal measures to reduce alcohol consumption are well-implemented. The legal minimum age for purchase is 21 years and restrictions of the times and places of alcohol availability and advertising are in place. Indonesia has yet to introduce a salt reduction policy. Health systems are responding well as 11 out of 12 essential medicines for noncommunicable diseases are available in primary care facilities.</p></sec><sec><title>Philippines</title><p>Although cigarettes were less affordable in 2016 than in 2008, the Philippines needs to further increase the tax rate (62.6%), improve compliance on smoke-free environments, increase the size of health warnings (50% of cigarette package areas) and increase compliance on bans on advertising and promotion. The country also needs to review the current legal minimum age (18&#x000a0;years) for sales of alcoholic beverages, introduce policies to limit daily salt consumption and increase the availability of essential medicines for clinical management in primary health care.</p></sec><sec><title>Sri Lanka</title><p>Although the tobacco tax rate is 62.1%, the lack of regular tax increases means that cigarettes are still affordable. Sri Lanka needs to further strengthen compliance on smoke-free environments and bans on advertising and promotion. The country is on the right path towards implementing salt reduction strategies and promotion of physical activity. Due to the strong emphasis on primary health care in the country, the availability of essential medicines at the primary care level has been ensured.</p></sec><sec><title>Thailand</title><p>Tobacco control is well-implemented with a high tax rate in place (73.5%), health warnings on 85% of the back and front package areas (which ranks third globally<xref rid="R1" ref-type="bibr"><sup>1</sup></xref>) and comprehensive regulations on advertising, market promotion and sponsorship. However, Thailand needs to improve compliance on smoke-free environments. Due to Thailand&#x02019;s policy of universal health coverage, nine essential medicines for noncommunicable diseases are available at primary care facilities.</p></sec><sec><title>Viet Nam</title><p>Lack of regular increase in tax has resulted in more affordable cigarettes in 2016 than in 2008. Viet Nam therefore needs to increase its tax rate (35.7%) improve compliance on smoke-free environments and increase health warnings from the current 50% of package areas. Increasing the current minimum legal age for sales of alcoholic beverage (18 years) may prevent youth drinking. The country needs to introduce policies to reduce daily salt intake (currently only dietary guidelines are available and there is no front-of-package labelling<xref rid="R1" ref-type="bibr"><sup>1</sup></xref>), promote physical activity, and ensure more essential noncommunicable diseases medicines are available in primary care facilities.</p></sec><fn-group><fn><p>Note: See <xref rid="T2" ref-type="table">Table&#x000a0;2</xref> for more details and data sources. Affordability of cigarettes is defined by the percentage of per capita gross domestic product required to purchase 2000 cigarettes of the most sold brand.<xref rid="R18" ref-type="bibr"><sup>18</sup></xref></p></fn></fn-group></boxed-text></sec><sec><title>Institutional capacity</title><p>Translating the UN General Assembly resolutions into interventions with good outcomes requires institutional capacity to deliver these political promises. We obtained information directly from health ministries on their institutional capacities for noncommunicable diseases (<xref rid="T3" ref-type="table">Table&#x000a0;3</xref>).</p><table-wrap id="T3" orientation="portrait" position="float"><label>Table 3</label><caption><title>Institutional capacity for the prevention and control of noncommunicable diseases in seven Asian countries in July 2018</title></caption><table frame="hsides" rules="groups"><col width="108" span="1"/><col width="76" span="1"/><col width="76" span="1"/><col width="76" span="1"/><col width="76" span="1"/><col width="76" span="1"/><col width="76" span="1"/><col width="76" span="1"/><thead><tr><th valign="top" align="left" scope="col" rowspan="1" colspan="1">Indicator</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Bhutan</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Cambodia</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Indonesia</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Philippines</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Sri Lanka</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Thailand</th><th valign="top" align="center" scope="col" rowspan="1" colspan="1">Viet Nam</th></tr></thead><tbody><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">No. of full-time equivalent technical professional staff in noncommunicable diseases unit under health ministry<sup>a</sup>
</td><td valign="top" align="center" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">7</td><td valign="top" align="center" rowspan="1" colspan="1">16</td><td valign="top" align="center" rowspan="1" colspan="1">19</td><td valign="top" align="center" rowspan="1" colspan="1">41</td><td valign="top" align="center" rowspan="1" colspan="1">39</td><td valign="top" align="center" rowspan="1" colspan="1">7</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">No. of full-time equivalent staff in health ministry for tobacco control<xref rid="R25" ref-type="bibr"><sup>25</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">14</td><td valign="top" align="center" rowspan="1" colspan="1">6</td><td valign="top" align="center" rowspan="1" colspan="1">12</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">10</td><td valign="top" align="center" rowspan="1" colspan="1">41</td><td valign="top" align="center" rowspan="1" colspan="1">20</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">National funding for noncommunicable diseases prevention, promotion, screening, treatment, surveillance, monitoring and evaluation, palliative care and research<sup>a</sup></td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">Yes, except research budget</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td><td valign="top" align="center" rowspan="1" colspan="1">Yes</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Sources of funding for noncommunicable diseases and their risk factors<sup>a</sup></td><td valign="top" align="center" rowspan="1" colspan="1">Government budget and donors</td><td valign="top" align="center" rowspan="1" colspan="1">Government budget, donors and social protection schemes</td><td valign="top" align="center" rowspan="1" colspan="1">Government budget and health insurance</td><td valign="top" align="center" rowspan="1" colspan="1">Government budget and health insurance</td><td valign="top" align="center" rowspan="1" colspan="1">Government budget and donors</td><td valign="top" align="center" rowspan="1" colspan="1">Government budget, health insurance and Thai Health Promotion Foundation</td><td valign="top" align="center" rowspan="1" colspan="1">Government budget, health insurance, donors and earmarked tobacco tax</td></tr><tr><td valign="top" align="left" scope="row" rowspan="1" colspan="1">Government expenditure on tobacco control (year), US$<xref rid="R25" ref-type="bibr"><sup>25</sup></xref></td><td valign="top" align="center" rowspan="1" colspan="1">23&#x02009;000 (2014)</td><td valign="top" align="center" rowspan="1" colspan="1">22&#x02009;200 (2008)</td><td valign="top" align="center" rowspan="1" colspan="1">882&#x02009;414 (2008)</td><td valign="top" align="center" rowspan="1" colspan="1">21&#x02009;739 (2007)</td><td valign="top" align="center" rowspan="1" colspan="1">462&#x02009;235 (2016)</td><td valign="top" align="center" rowspan="1" colspan="1">892&#x02009;359 (2015)</td><td valign="top" align="center" rowspan="1" colspan="1">12&#x02009;000&#x02009;000 (2016)</td></tr></tbody></table><table-wrap-foot><p>US$: United States dollar.</p><p><sup>a</sup> Personal communication with health ministries.</p></table-wrap-foot></table-wrap><p>All seven countries had designated a unit or equivalent body in their health ministry with responsibility for noncommunicable diseases. The number of full-time equivalent professional staff in the unit ranged from four in Bhutan to 41 in Sri Lanka. As required by the WHO FCTC reporting, the number of full-time equivalent for tobacco control ranged from three in the Philippines to 41 in Thailand.</p><p>Funding for noncommunicable diseases interventions (including prevention, promotion, screening, treatment, surveillance, monitoring and evaluation, capacity-building, palliative care and research) were available in all seven countries, except for a research budget in Cambodia.</p><p>Data were not available on annual spending on noncommunicable diseases, although all countries relied on government budget allocation and a small proportion of donor funding. Health insurance subsidized the cost of treatment in Cambodia, Indonesia, Philippines, Thailand and Viet Nam. A 2% additional surcharge from a tobacco and alcohol excise tax was earmarked and managed by the Thai Health Promotion Foundation<xref rid="R29" ref-type="bibr"><sup>29</sup></xref> for comprehensive interventions for noncommunicable diseases and other risk factors. An earmarked tax from alcohol and tobacco sales in the Philippines is used to subsidize health care in general, for the 40% of the population who are low income, and Viet Nam has earmarked the tobacco tax for the tobacco control programme. A great variation on annual spending on tobacco control was noted in these countries, ranging from US$&#x02009;21&#x02009;739 in the Philippines to US$&#x02009;12 million in Viet Nam (<xref rid="T3" ref-type="table">Table&#x000a0;3</xref>).</p></sec></sec><sec><title>Challenges</title><sec><title>Implementation gaps</title><p>Institutional capacity assessment in the seven countries is constrained by several limitations. Disaggregated information on the skill-mix of technical staff in countries&#x02019; health ministry noncommunicable diseases units, and staff turnover rate, are not routinely recorded and reported. This evidence is critical for analysing gaps and strengthening the capacity of noncommunicable disease units. In the countries we analysed, information was also lacking on government spending on health promotion interventions. Using the WHO Health Accounts database,<xref rid="R30" ref-type="bibr"><sup>30</sup></xref> we estimate that the global average investment on health promotion and public health interventions worldwide in 2012 was 4.3% of current per capita health spending (US$&#x02009;38.6 of US$&#x02009;989.2). Despite the well-established monitoring and evaluation system of the WHO FCTC, data on expenditure for tobacco control is not routinely updated for many countries. For example, the latest expenditure data on tobacco control in the Cambodia, Indonesia and Philippines were outdated, from 2008, 2008 and 2007, respectively.</p><p>Taxation on tobacco and alcohol has not reached the global targets in these seven countries, mainly due to the lack of multisectoral action to enforce legislative decisions on taxing these harmful products and counteracting industry interference. These concerns were highlighted by the UN Interagency Task Force on noncommunicable diseases conducted in these countries.<xref rid="R31" ref-type="bibr"><sup>31</sup></xref> Furthermore, primary prevention efforts in the seven countries are hampered by weak regulatory capacities, inadequate legal consequences for law violation and conflicts of interests among government officials. Regulatory gaps were illustrated by poor enforcement of smoke-free environments or of bans on tobacco advertising and promotion. Besides Sri Lanka and Thailand, integration of noncommunicable disease interventions at the primary care level need to be strengthened in the remaining five countries, to ensure essential medicines for clinical management, prevention of complications and premature mortality. Funding gaps for noncommunicable diseases, as reported by health ministries, remain an important national agenda in these countries and the governments need to invest more on effective interventions such as the recommended best buys, intersectoral actions and health-system responses for noncommunicable diseases.</p><p>Another possible explanation for insufficient progress of noncommunicable diseases prevention policy is industry interference.<xref rid="R32" ref-type="bibr"><sup>32</sup></xref> There is evidence from other countries that the tobacco,<xref rid="R33" ref-type="bibr"><sup>33</sup></xref><sup>&#x02013;</sup><xref rid="R35" ref-type="bibr"><sup>35</sup></xref> alcohol,<xref rid="R36" ref-type="bibr"><sup>36</sup></xref> food and beverage industries<xref rid="R37" ref-type="bibr"><sup>37</sup></xref> use tactics to interfere with policies aimed at reducing consumption of their unhealthy products. </p><p>The South East Asia Tobacco Control Alliance has pioneered the Tobacco Industry Interference Index to monitor tobacco industry actions.<xref rid="R38" ref-type="bibr"><sup>38</sup></xref> Viet Nam and Indonesia have demonstrated high levels of industry interference,<xref rid="R39" ref-type="bibr"><sup>39</sup></xref> with marginal improvement between 2015 and 2016, which may be linked to the lack of progress on tobacco control in both countries. The tobacco industry has been more effective in promoting their products than governments have been in implementing effective interventions, as reflected by the slow progress in tobacco control efforts in the countries we analysed. In Indonesia, a non-State Party to the WHO FCTC, the level of tobacco industry interference is the highest, although the health ministry is drafting guidelines for interaction with the tobacco industry.<xref rid="R40" ref-type="bibr"><sup>40</sup></xref> Article 5.3 of the WHO FCTC guides State Parties to protect their tobacco control policies from the vested interests of the tobacco industry.<xref rid="R41" ref-type="bibr"><sup>41</sup></xref> Global experience shows how the tobacco industry&#x02019;s corporate social responsibility activities are a platform for government officials to participate directly in the industry&#x02019;s activities. All countries in this study have yet to establish procedures for disclosing interactions between governments and the industry.</p><p>Industry interference with government policies is further highlighted by Thailand&#x02019;s experience in introducing an excise tax on beverages containing sugar in 2017,<xref rid="R42" ref-type="bibr"><sup>42</sup></xref> where the government faced resistance by the Thai Beverage Industry Association that challenged the links between obesity and drinking soda.<xref rid="R43" ref-type="bibr"><sup>43</sup></xref></p><p>To address the commercial determinants of noncommunicable diseases and policy interference by industries, countries require improved governance, political leadership and a whole-of-government approach to making legislative decisions on taxation and strengthening regulatory capacities.</p></sec><sec><title>Monitoring and evaluation gaps</title><p>The existing systems for surveillance of health risks, including the prevalence of smoking, alcohol per capita consumption, daily salt intake and levels of physical inactivity, need strengthening, standardization and integration for comprehensive noncommunicable diseases policies to be formulated. Integrated household surveys such as the <italic>STEPwise approach to surveillance</italic><xref rid="R44" ref-type="bibr"><sup>44</sup></xref> or equivalent should cover all noncommunicable diseases risks in one survey.</p><p>The lack of global standardized detail reporting on alcohol control hampers countries from monitoring and advancing the alcohol control agenda; for example, monitoring tax rates against the preferred level of tax rate, similar to the FCTC MPOWER report.<xref rid="R18" ref-type="bibr"><sup>18</sup></xref> Estimations of daily salt intake requires laboratory testing to quantify 24-hour urinary sodium excretion,<xref rid="R45" ref-type="bibr"><sup>45</sup></xref> and only a few countries worldwide conduct such surveys.<xref rid="R46" ref-type="bibr"><sup>46</sup></xref><sup>,</sup><xref rid="R47" ref-type="bibr"><sup>47</sup></xref> The burdensome 24-hour collection of urine can be replaced by urine spot testing,<xref rid="R48" ref-type="bibr"><sup>48</sup></xref> which is more practical and less costly. Salt intake using spot urine samples can provide countries with a good indication of mean population salt intake.<xref rid="R49" ref-type="bibr"><sup>49</sup></xref> The level of daily salt intake is a powerful message for policy advocacy in educating the public and benchmarking with international peers. Monitoring measures for unhealthy diet reduction need to be more comprehensive. Such monitoring needs to cover people&#x02019;s consumption of trans-fat and sugar-sweetened beverages; policy interventions such as introduction of sugar-sweetened beverages taxes and bans on trans-fat in food; and the food industries&#x02019; responses and adherence to policy.</p><p>Learning from the FCTC global tobacco epidemic report,<xref rid="R18" ref-type="bibr"><sup>18</sup></xref> the WHO and international partners should develop a standardized, comprehensive monitoring tool on alcohol, salt, unhealthy food, physical activity and primary health-care readiness to provide noncommunicable diseases services. The indicators in the country capacity survey<xref rid="R24" ref-type="bibr"><sup>24</sup></xref> are inadequate to drive health-systems responses to noncommunicable diseases.</p></sec></sec><sec sec-type="conclusions"><title>Conclusion</title><p>Our survey identified more challenges than achievements in these seven Asian countries, although some progress has been made since implementing their national action plans on noncommunicable diseases control. Key underlying barriers for insufficient progress of noncommunicable disease policy are the lack of institutional capacities of noncommunicable disease units in managing action across different sectors; inadequate investment on primary prevention; and inadequate health-systems responses on clinical management. The multifactorial nature of noncommunicable disease requires coordinated health action across sectors within and outside the health system, including tax policies, health policies, food policies, transport and urban design. To overcome implementation gaps, governments need to improve the coordination of noncommunicable diseases units with other sectors, invest more in effective interventions such as the WHO recommended best buys, and improve monitoring and evaluation capacities.</p></sec></body><back><ack><title>Acknowledgments</title><p>We acknowledge the contributions of technical staff in the noncommunicable diseases units in the health ministry in all seven countries.</p></ack><fn-group><title>Competing interests:</title><fn fn-type="financial-disclosure"><p>None declared.</p></fn></fn-group><ref-list><title>References</title><ref id="R1"><label>1</label><mixed-citation publication-type="journal"><string-name><surname>Nugent</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Bertram</surname>
<given-names>MY</given-names></string-name>, <string-name><surname>Jan</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Niessen</surname>
<given-names>LW</given-names></string-name>, <string-name><surname>Sassi</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Jamison</surname>
<given-names>DT</given-names></string-name>, <etal>et al.</etal>
<article-title>Investing in non-communicable disease prevention and management to advance the Sustainable Development Goals.</article-title>
<source>Lancet</source>. <year>2018</year>
<month>5</month>
<day>19</day>;<volume>391</volume>(<issue>10134</issue>):<fpage>2029</fpage>&#x02013;<lpage>35</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(18)30667-6</pub-id><pub-id pub-id-type="pmid">29627167</pub-id></mixed-citation></ref><ref id="R2"><label>2</label><mixed-citation publication-type="web">Political declaration of the third high-level meeting of the General Assembly on the prevention and control of non-communicable diseases. UNGA 73.2. New York: United Nations; 2018. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.un.org/en/ga/search/view_doc.asp?symbol=A/RES/73/2">http://www.un.org/en/ga/search/view_doc.asp?symbol=A/RES/73/2</ext-link> [cited 2018 Nov 3]. </mixed-citation></ref><ref id="R3"><label>3</label><mixed-citation publication-type="web">WHO Global Action Plan for the prevention and control of noncommunicable diseases 2013&#x02013;2020. Geneva: World Health Organization; 2015. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/nmh/events/ncd_action_plan/en/">http://www.who.int/nmh/events/ncd_action_plan/en/</ext-link><ext-link ext-link-type="uri" xlink:href="http://"/>[cited 2018 Jul 10]. </mixed-citation></ref><ref id="R4"><label>4</label><mixed-citation publication-type="web">Health in 2015: from MDGs, millennium development goals to SDGs, sustainable development goals [internet]. Geneva: World Health Organization; 2015. Available from: <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/iris/bitstream/handle/10665/200009/9789241565110_eng.pdf?sequence=1">http://apps.who.int/iris/bitstream/handle/10665/200009/9789241565110_eng.pdf?sequence=1</ext-link><ext-link ext-link-type="uri" xlink:href="http://"/>[cited 2018 Jul 11].</mixed-citation></ref><ref id="R5"><label>5</label><mixed-citation publication-type="web">Time to deliver: report of the WHO Independent High-level Commission on Noncommunicable Diseases. Geneva: World Health Organization; 2018 Available from: <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/iris/bitstream/handle/10665/272710/9789241514163-eng.pdf?ua=1">http://apps.who.int/iris/bitstream/handle/10665/272710/9789241514163-eng.pdf?ua=1</ext-link><ext-link ext-link-type="uri" xlink:href="http://"/>[cited 2018 Jul 11]. </mixed-citation></ref><ref id="R6"><label>6</label><mixed-citation publication-type="web">Montevideo roadmap 2018&#x02013;2030 on NCDs as a sustainable development priority. Geneva: World Health Organization; 2017. Available from <ext-link ext-link-type="uri" xlink:href="http://www.who.int/conferences/global-ncd-conference/Roadmap.pdf">http://www.who.int/conferences/global-ncd-conference/Roadmap.pdf</ext-link> [cited 2018 Nov 26].</mixed-citation></ref><ref id="R7"><label>7</label><mixed-citation publication-type="web">Saving lives, spending less: a strategic response to noncommunicable diseases. Geneva: World Health Organization; 2018. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/ncds/management/ncds-strategic-response/en/">http://www.who.int/ncds/management/ncds-strategic-response/en/</ext-link> [cited 2018, Nov, 24].</mixed-citation></ref><ref id="R8"><label>8</label><mixed-citation publication-type="web">Financing global health 2015: development assistance steady on the path to new global goals. Seattle: Institute for Health Metrics and Evaluation; 2016. Available from: <ext-link ext-link-type="uri" xlink:href="https://bit.ly/2P5pJ7G">https://bit.ly/2P5pJ7G</ext-link> [cited 2018 Nov 28].</mixed-citation></ref><ref id="R9"><label>9</label><mixed-citation publication-type="journal"><string-name><surname>Horton</surname>
<given-names>R</given-names></string-name>. <article-title>Offline: NCDs-why are we failing?</article-title>
<source>Lancet</source>. <year>2017</year>
<month>7</month>
<day>22</day>;<volume>390</volume>(<issue>10092</issue>):<fpage>346</fpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(17)31919-0</pub-id><pub-id pub-id-type="pmid">28745593</pub-id></mixed-citation></ref><ref id="R10"><label>10</label><mixed-citation publication-type="journal"><string-name><surname>Nugent</surname>
<given-names>R</given-names></string-name>. <article-title>A chronology of global assistance funding for NCD.</article-title>
<source>Glob Heart</source>. <year>2016</year>
<month>12</month>;<volume>11</volume>(<issue>4</issue>):<fpage>371</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/j.gheart.2016.10.027</pub-id><pub-id pub-id-type="pmid">27938820</pub-id></mixed-citation></ref><ref id="R11"><label>11</label><mixed-citation publication-type="journal"><string-name><surname>Clark</surname>
<given-names>H</given-names></string-name>. <article-title>NCDs: a challenge to sustainable human development.</article-title>
<source>Lancet</source>. <year>2013</year>
<month>2</month>
<day>16</day>;<volume>381</volume>(<issue>9866</issue>):<fpage>510</fpage>&#x02013;<lpage>1</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(13)60058-6</pub-id><pub-id pub-id-type="pmid">23410604</pub-id></mixed-citation></ref><ref id="R12"><label>12</label><mixed-citation publication-type="web">NCD financing [internet]. Geneva: World Health Organization; 2016. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/global-coordination-mechanism/ncd-themes/ncd-financing/en/">http://www.who.int/global-coordination-mechanism/ncd-themes/ncd-financing/en/</ext-link> [cited 2018 Jul 11].</mixed-citation></ref><ref id="R13"><label>13</label><mixed-citation publication-type="journal"><string-name><surname>Ghebreyesus</surname>
<given-names>TA</given-names></string-name>. <article-title>Acting on NCDs: counting the cost.</article-title>
<source>Lancet</source>. <year>2018</year>
<month>5</month>
<day>19</day>;<volume>391</volume>(<issue>10134</issue>):<fpage>1973</fpage>&#x02013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(18)30675-5</pub-id><pub-id pub-id-type="pmid">29627165</pub-id></mixed-citation></ref><ref id="R14"><label>14</label><mixed-citation publication-type="web">New country classifications by income level: 2017&#x02013;2018. The data blog [internet]. Washington: World Bank; 2017. Available from: <ext-link ext-link-type="uri" xlink:href="https://blogs.worldbank.org/opendata/new-country-classifications-income-level-2017-2018">https://blogs.worldbank.org/opendata/new-country-classifications-income-level-2017-2018</ext-link><ext-link ext-link-type="uri" xlink:href="http://"/>[cited 2018 Jul 11]. </mixed-citation></ref><ref id="R15"><label>15</label><mixed-citation publication-type="web">World development indicators (WDI). Data catalog [internet]. Washington: World Bank; 2017. Available from: <ext-link ext-link-type="uri" xlink:href="https://datacatalog.worldbank.org/dataset/world-development-indicators">https://datacatalog.worldbank.org/dataset/world-development-indicators</ext-link>[cited 2018 Jul 11]. </mixed-citation></ref><ref id="R16"><label>16</label><mixed-citation publication-type="web">Country cards [internet]. San Diego: Global Observatory for Physical Activity; 2018. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.globalphysicalactivityobservatory.com/country-cards/">http://www.globalphysicalactivityobservatory.com/country-cards/</ext-link> [cited 2018 Nov 24].</mixed-citation></ref><ref id="R17"><label>17</label><mixed-citation publication-type="web">Global status report on alcohol and health 2014. Geneva: World Health Organization; 2014, Available from: <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/iris/bitstream/handle/10665/112736/9789240692763_eng.pdf?sequence=1">http://apps.who.int/iris/bitstream/handle/10665/112736/9789240692763_eng.pdf?sequence=1</ext-link> [cited 2018 Nov 24].</mixed-citation></ref><ref id="R18"><label>18</label><mixed-citation publication-type="web">WHO report on the global tobacco epidemic, 2017. Monitoring tobacco use and prevention policies. Geneva: World Health Organization; 2017. Available from: <ext-link ext-link-type="uri" xlink:href="https://bit.ly/2Kw6e7F">https://bit.ly/2Kw6e7F</ext-link> [cited 2018 Nov 24].</mixed-citation></ref><ref id="R19"><label>19</label><mixed-citation publication-type="web">Global status report on alcohol and health 2018. Geneva: World Health Organization; 2018 Available from: <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/iris/bitstream/handle/10665/274603/9789241565639-eng.pdf?ua=1">http://apps.who.int/iris/bitstream/handle/10665/274603/9789241565639-eng.pdf?ua=1</ext-link> [cited 2018 Nov 3].</mixed-citation></ref><ref id="R20"><label>20</label><mixed-citation publication-type="web">WHO Global status report on noncommunicable diseases 2010. World Health Organization; 2011. Available from: <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/iris/bitstream/handle/10665/44579/9789240686458_eng.pdf?sequence=1">http://apps.who.int/iris/bitstream/handle/10665/44579/9789240686458_eng.pdf?sequence=1</ext-link> [cited 2018, Nov, 24].</mixed-citation></ref><ref id="R21"><label>21</label><mixed-citation publication-type="web">Noncommunicable diseases progress monitor 2017. Geneva: World Health Organization; 2017. Available from: <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/iris/bitstream/handle/10665/258940/9789241513029-eng.pdf?sequence=1">http://apps.who.int/iris/bitstream/handle/10665/258940/9789241513029-eng.pdf?sequence=1</ext-link> [cited 2018 Nov 24].</mixed-citation></ref><ref id="R22"><label>22</label><mixed-citation publication-type="web">Global Health Observatory data repository [internet]. Geneva: World Health Organization; 2018. Available from: <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/gho/data/?theme=main">http://apps.who.int/gho/data/?theme=main</ext-link><ext-link ext-link-type="uri" xlink:href="http://"/>[cited 2018 Nov 3].</mixed-citation></ref><ref id="R23"><label>23</label><mixed-citation publication-type="web">Noncommunicable diseases country profiles 2018 [internet]. Geneva: World Health Organization; 2018. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/nmh/publications/ncd-profiles-2018/en/">https://www.who.int/nmh/publications/ncd-profiles-2018/en/</ext-link>[cited 2018 Nov 3].</mixed-citation></ref><ref id="R24"><label>24</label><mixed-citation publication-type="web">Noncommunicable diseases progress monitor 2017. Geneva: World Health Organization; 2017. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/nmh/publications/ncd-progress-monitor-2017/en/">http://www.who.int/nmh/publications/ncd-progress-monitor-2017/en/</ext-link> [cited 2018 Nov 24].</mixed-citation></ref><ref id="R25"><label>25</label><mixed-citation publication-type="web">Tobacco control country profiles, 2013. Geneva: World Health Organization; 2013. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/tobacco/global_report/2013/appendix_vii.pdf?ua=1">http://www.who.int/tobacco/global_report/2013/appendix_vii.pdf?ua=1</ext-link> [cited 2018 Nov 24].</mixed-citation></ref><ref id="R26"><label>26</label><mixed-citation publication-type="journal"><string-name><surname>Mohani</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Prabhakaranii</surname>
<given-names>D</given-names></string-name>, <string-name><surname>Krishnan</surname>
<given-names>A</given-names></string-name>. <article-title>Promoting populationwide salt reduction in the South-East Asia Region: current status and future directions.</article-title>
<source>Reg Health Forum</source>. <year>2013</year>;<volume>17</volume>(<issue>1</issue>):<fpage>72</fpage>&#x02013;<lpage>9</lpage>. Available from <ext-link ext-link-type="uri" xlink:href="https://bit.ly/2CViNYh">https://bit.ly/2CViNYh</ext-link>
<comment>[cited 2018 Nov 25]</comment>.</mixed-citation></ref><ref id="R27"><label>27</label><mixed-citation publication-type="book"><source>Guideline: sodium intake for adults and children.</source>
<publisher-loc>Geneva</publisher-loc>
<publisher-name>World Health Organization</publisher-name>; <year>2012</year>.</mixed-citation></ref><ref id="R28"><label>28</label><mixed-citation publication-type="web">WHO global action plan on physical activity 2018&#x02013;2030. Geneva: World Health Organization; 2018. Available from: <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/iris/bitstream/handle/10665/272722/9789241514187-eng.pdf">http://apps.who.int/iris/bitstream/handle/10665/272722/9789241514187-eng.pdf</ext-link> [cited 2018 Nov 3]. </mixed-citation></ref><ref id="R29"><label>29</label><mixed-citation publication-type="book"><string-name><surname>Tangcharoensathien</surname>
<given-names>V</given-names></string-name>, <string-name><surname>Sopitarchasak</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Viriyathorn</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Supaka</surname>
<given-names>N</given-names></string-name>, <string-name><surname>Tisayaticom</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Laptikultham</surname>
<given-names>S</given-names></string-name>, <etal>et al.</etal>
<chapter-title>Innovative financing for health promotion: a global review and Thailand case study.</chapter-title> In: <string-name><surname>Quah</surname>
<given-names>SR</given-names></string-name>, <string-name><surname>Cockerham</surname>
<given-names>WC</given-names></string-name>, editors. <source>The international encyclopedia of public health.</source>
<volume>Volume 4</volume>
<edition>2nd ed.</edition>
<publisher-loc>Oxford</publisher-loc>: <publisher-name>Academic Press</publisher-name>; <year>2017</year> pp. <fpage>275</fpage>&#x02013;<lpage>87</lpage>. <pub-id pub-id-type="doi">10.1016/B978-0-12-803678-5.00234-4</pub-id></mixed-citation></ref><ref id="R30"><label>30</label><mixed-citation publication-type="web">Health accounts [internet]. Geneva: World Health Organization; 2014. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/health-accounts/en/">https://www.who.int/health-accounts/en/</ext-link> [cited 2018 Nov 4]. </mixed-citation></ref><ref id="R31"><label>31</label><mixed-citation publication-type="web">UN Interagency Task Force on noncommunicable diseases. Geneva: World Health Organization; 2018. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/ncds/un-task-force/en/">http://www.who.int/ncds/un-task-force/en/</ext-link><ext-link ext-link-type="uri" xlink:href="http://"/>[cited 2018 Nov 4]. </mixed-citation></ref><ref id="R32"><label>32</label><mixed-citation publication-type="journal"><string-name><surname>Kickbusch</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Allen</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Franz</surname>
<given-names>C</given-names></string-name>. <article-title>The commercial determinants of health.</article-title>
<source>Lancet Glob Health</source>. <year>2016</year>
<month>12</month>;<volume>4</volume>(<issue>12</issue>):<fpage>e895</fpage>&#x02013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/S2214-109X(16)30217-0</pub-id><pub-id pub-id-type="pmid">27855860</pub-id></mixed-citation></ref><ref id="R33"><label>33</label><mixed-citation publication-type="journal"><string-name><surname>Saloojee</surname>
<given-names>Y</given-names></string-name>, <string-name><surname>Dagli</surname>
<given-names>E</given-names></string-name>. <article-title>Tobacco industry tactics for resisting public policy on health.</article-title>
<source>Bull World Health Organ</source>. <year>2000</year>;<volume>78</volume>(<issue>7</issue>):<fpage>902</fpage>&#x02013;<lpage>10</lpage>.<pub-id pub-id-type="pmid">10994263</pub-id></mixed-citation></ref><ref id="R34"><label>34</label><mixed-citation publication-type="journal"><string-name><surname>Rosenberg</surname>
<given-names>NJ</given-names></string-name>, <string-name><surname>Siegel</surname>
<given-names>M</given-names></string-name>. <article-title>Use of corporate sponsorship as a tobacco marketing tool: a review of tobacco industry sponsorship in the USA, 1995&#x02013;99.</article-title>
<source>Tob Control</source>. <year>2001</year>
<month>9</month>;<volume>10</volume>(<issue>3</issue>):<fpage>239</fpage>&#x02013;<lpage>46</lpage>. <pub-id pub-id-type="doi">10.1136/tc.10.3.239</pub-id><pub-id pub-id-type="pmid">11544388</pub-id></mixed-citation></ref><ref id="R35"><label>35</label><mixed-citation publication-type="journal"><string-name><surname>Chapman</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Carter</surname>
<given-names>SM</given-names></string-name>. <article-title>&#x0201c;Avoid health warnings on all tobacco products for just as long as we can&#x0201d;: a history of Australian tobacco industry efforts to avoid, delay and dilute health warnings on cigarettes.</article-title>
<source>Tob Control</source>. <year>2003</year>
<month>12</month>;<volume>12</volume>(<issue>90003</issue>) <supplement>Suppl 3</supplement>:<fpage>iii13</fpage>&#x02013;<lpage>22</lpage>. <pub-id pub-id-type="doi">10.1136/tc.12.suppl_3.iii13</pub-id><pub-id pub-id-type="pmid">14645944</pub-id></mixed-citation></ref><ref id="R36"><label>36</label><mixed-citation publication-type="journal"><string-name><surname>Martino</surname>
<given-names>FP</given-names></string-name>, <string-name><surname>Miller</surname>
<given-names>PG</given-names></string-name>, <string-name><surname>Coomber</surname>
<given-names>K</given-names></string-name>, <string-name><surname>Hancock</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Kypri</surname>
<given-names>K</given-names></string-name>. <article-title>Analysis of alcohol industry submissions against marketing regulation.</article-title>
<source>PLoS One</source>. <year>2017</year>
<month>1</month>
<day>24</day>;<volume>12</volume>(<issue>1</issue>):<fpage>e0170366</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0170366</pub-id><pub-id pub-id-type="pmid">28118411</pub-id></mixed-citation></ref><ref id="R37"><label>37</label><mixed-citation publication-type="journal"><string-name><surname>Mialon</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Swinburn</surname>
<given-names>B</given-names></string-name>, <string-name><surname>Wate</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Tukana</surname>
<given-names>I</given-names></string-name>, <string-name><surname>Sacks</surname>
<given-names>G</given-names></string-name>. <article-title>Analysis of the corporate political activity of major food industry actors in Fiji.</article-title>
<source>Global Health</source>. <year>2016</year>
<month>5</month>
<day>10</day>;<volume>12</volume>(<issue>1</issue>):<fpage>18</fpage>. <pub-id pub-id-type="doi">10.1186/s12992-016-0158-8</pub-id><pub-id pub-id-type="pmid">27160250</pub-id></mixed-citation></ref><ref id="R38"><label>38</label><mixed-citation publication-type="web">Kolandai MA. Tobacco Industry Interference Index. ASEAN Report of Implementation of WHO Framework Convention on Tobacco Control Article 5.3. Bangkok: Southeast Asia Tobacco Control Alliance; 2017. Available from: <ext-link ext-link-type="uri" xlink:href="https://seatca.org/dmdocuments/TI%20Index%202017%209%20November%20FINAL.pdf">https://seatca.org/dmdocuments/TI%20Index%202017%209%20November%20FINAL.pdf</ext-link> [cited 2018 Nov 24].</mixed-citation></ref><ref id="R39"><label>39</label><mixed-citation publication-type="journal"><string-name><surname>Gilmore</surname>
<given-names>AB</given-names></string-name>, <string-name><surname>Fooks</surname>
<given-names>G</given-names></string-name>, <string-name><surname>Drope</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Bialous</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Jackson</surname>
<given-names>RR</given-names></string-name>. <article-title>Exposing and addressing tobacco industry conduct in low-income and middle-income countries.</article-title>
<source>Lancet</source>. <year>2015</year>
<month>3</month>
<day>14</day>;<volume>385</volume>(<issue>9972</issue>):<fpage>1029</fpage>&#x02013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1016/S0140-6736(15)60312-9</pub-id><pub-id pub-id-type="pmid">25784350</pub-id></mixed-citation></ref><ref id="R40"><label>40</label><mixed-citation publication-type="journal"><string-name><surname>Tandilittin</surname>
<given-names>H</given-names></string-name>, <string-name><surname>Luetge</surname>
<given-names>C</given-names></string-name>. <article-title>Civil society and tobacco control in Indonesia: the last resort.</article-title>
<source>Open Ethics Journal.</source>
<year>2013</year>;<volume>7</volume>(<issue>7</issue>):<fpage>11</fpage>&#x02013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.2174/1874761201307010011</pub-id></mixed-citation></ref><ref id="R41"><label>41</label><mixed-citation publication-type="web">Guidelines for implementation of article 5.3 of the WHO Framework Convention on Tobacco Control. Geneva: World Health Organization; 2013. Available from: <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/iris/bitstream/10665/80510/1/9789241505185_eng.pdf?ua=1">http://apps.who.int/iris/bitstream/10665/80510/1/9789241505185_eng.pdf?ua=1</ext-link> [cited 2018 Jul 15]. </mixed-citation></ref><ref id="R42"><label>42</label><mixed-citation publication-type="web">Global Agricultural Information Network. Thai Excise Department Implements new sugar tax on beverages. GAIN report no. TH7138. Washington: United States Department of Agriculture Foreign Agriculture Service; 2017. Available from: <ext-link ext-link-type="uri" xlink:href="https://bit.ly/2zCbFfz">https://bit.ly/2zCbFfz</ext-link><ext-link ext-link-type="uri" xlink:href="http://"/>[cited 2018 Jul 10]. </mixed-citation></ref><ref id="R43"><label>43</label><mixed-citation publication-type="web">Thailand one of many countries waging war on sugar via a tax on sweetened soft drinks. The Nation 2016. May 14. Available from: <ext-link ext-link-type="uri" xlink:href="https://bit.ly/2uuBaOe">https://bit.ly/2uuBaOe</ext-link><ext-link ext-link-type="uri" xlink:href="http://"/>[cited 2018 Jul 10]. </mixed-citation></ref><ref id="R44"><label>44</label><mixed-citation publication-type="web">STEPwise approach to surveillance (STEPS) [internet]. Geneva: World Health Organization. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.who.int/ncds/surveillance/steps/en/">https://www.who.int/ncds/surveillance/steps/en/</ext-link><ext-link ext-link-type="uri" xlink:href="http://"/>[cited 2018 Nov 3]. </mixed-citation></ref><ref id="R45"><label>45</label><mixed-citation publication-type="journal"><string-name><surname>Zhang</surname>
<given-names>J-Y</given-names></string-name>, <string-name><surname>Yan</surname>
<given-names>L-X</given-names></string-name>, <string-name><surname>Tang</surname>
<given-names>J-L</given-names></string-name>, <string-name><surname>Ma</surname>
<given-names>J-X</given-names></string-name>, <string-name><surname>Guo</surname>
<given-names>X-L</given-names></string-name>, <string-name><surname>Zhao</surname>
<given-names>W-H</given-names></string-name>, <etal>et al.</etal>
<article-title>Estimating daily salt intake based on 24&#x02005;h urinary sodium excretion in adults aged 18-69&#x02005;years in Shandong, China.</article-title>
<source>BMJ Open</source>. <year>2014</year>
<month>7</month>
<day>18</day>;<volume>4</volume>(<issue>7</issue>):<fpage>e005089</fpage>. <pub-id pub-id-type="doi">10.1136/bmjopen-2014-005089</pub-id><pub-id pub-id-type="pmid">25037642</pub-id></mixed-citation></ref><ref id="R46"><label>46</label><mixed-citation publication-type="journal"><string-name><surname>Batcagan-Abueg</surname>
<given-names>AP</given-names></string-name>, <string-name><surname>Lee</surname>
<given-names>JJ</given-names></string-name>, <string-name><surname>Chan</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Rebello</surname>
<given-names>SA</given-names></string-name>, <string-name><surname>Amarra</surname>
<given-names>MS</given-names></string-name>. <article-title>Salt intakes and salt reduction initiatives in Southeast Asia: a review.</article-title>
<source>Asia Pac J Clin Nutr</source>. <year>2013</year>;<volume>22</volume>(<issue>4</issue>):<fpage>490</fpage>&#x02013;<lpage>504</lpage>.<pub-id pub-id-type="pmid">24231008</pub-id></mixed-citation></ref><ref id="R47"><label>47</label><mixed-citation publication-type="journal"><string-name><surname>Powles</surname>
<given-names>J</given-names></string-name>, <string-name><surname>Fahimi</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Micha</surname>
<given-names>R</given-names></string-name>, <string-name><surname>Khatibzadeh</surname>
<given-names>S</given-names></string-name>, <string-name><surname>Shi</surname>
<given-names>P</given-names></string-name>, <string-name><surname>Ezzati</surname>
<given-names>M</given-names></string-name>, <etal>et al.</etal>; <collab>Global Burden of Diseases Nutrition and Chronic Diseases Expert Group (NutriCoDE)</collab>. <article-title>Global, regional and national sodium intakes in 1990 and 2010: a systematic analysis of 24 h urinary sodium excretion and dietary surveys worldwide.</article-title>
<source>BMJ Open</source>. <year>2013</year>
<month>12</month>
<day>23</day>;<volume>3</volume>(<issue>12</issue>):<fpage>e003733</fpage>. <pub-id pub-id-type="doi">10.1136/bmjopen-2013-003733</pub-id><pub-id pub-id-type="pmid">24366578</pub-id></mixed-citation></ref><ref id="R48"><label>48</label><mixed-citation publication-type="journal"><string-name><surname>Hooft van Huysduynen</surname>
<given-names>EJ</given-names></string-name>, <string-name><surname>Hulshof</surname>
<given-names>PJ</given-names></string-name>, <string-name><surname>van Lee</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Geelen</surname>
<given-names>A</given-names></string-name>, <string-name><surname>Feskens</surname>
<given-names>EJ</given-names></string-name>, <string-name><surname>van &#x02019;t Veer</surname>
<given-names>P</given-names></string-name>, <etal>et al.</etal>
<article-title>Evaluation of using spot urine to replace 24 h urine sodium and potassium excretions.</article-title>
<source>Public Health Nutr</source>. <year>2014</year>
<month>11</month>;<volume>17</volume>(<issue>11</issue>):<fpage>2505</fpage>&#x02013;<lpage>11</lpage>. <pub-id pub-id-type="doi">10.1017/S1368980014001177</pub-id><pub-id pub-id-type="pmid">24909492</pub-id></mixed-citation></ref><ref id="R49"><label>49</label><mixed-citation publication-type="journal"><string-name><surname>Huang</surname>
<given-names>L</given-names></string-name>, <string-name><surname>Crino</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Wu</surname>
<given-names>JH</given-names></string-name>, <string-name><surname>Woodward</surname>
<given-names>M</given-names></string-name>, <string-name><surname>Barzi</surname>
<given-names>F</given-names></string-name>, <string-name><surname>Land</surname>
<given-names>MA</given-names></string-name>, <etal>et al.</etal>
<article-title>Mean population salt intake estimated from 24-h urine samples and spot urine samples: a systematic review and meta-analysis.</article-title>
<source>Int J Epidemiol</source>. <year>2016</year>
<month>2</month>;<volume>45</volume>(<issue>1</issue>):<fpage>239</fpage>&#x02013;<lpage>50</lpage>. <pub-id pub-id-type="doi">10.1093/ije/dyv313</pub-id><pub-id pub-id-type="pmid">26796216</pub-id></mixed-citation></ref></ref-list></back></article>